EurekaMag PDF full texts Chapter 10,774
References:
Segerer, S.; Bogner, J.R.; Walli, R.; Loch, O.; Goebel, F.D. 1999: Hyperlipidemia under treatment with proteinase inhibitors. Infection 27(2): 77-81
Hart, B.J.; Bian, X.; Mallet, R.T.; Downey, H.F. 2000: Hyperlipidemia with hypoglycemia reduces myocardial oxygen utilization efficiency but not contractile function during coronary hypoperfusion. Journal of Molecular and Cellular Cardiology 32(8): 1539-1552
Castelló, I.B. 2002: Hyperlipidemia: a risk factor for chronic allograft dysfunction. Kidney International. Suppl 80: 73-77
Montilla, P.; Túnez, I.; Muñoz, M.C.; Delgado, M.J.; Salcedo, M. 2000: Hyperlipidemic nephropathy induced by adriamycin in ovariectomized rats: role of free radicals and effect of 17-beta-estradiol administration. Nephron 85(1): 65-70
Mohrschladt, M.F.; Weverling-Rijnsburger, A.W.; de Man, F.H.; Stoeken, D.J.; Sturk, A.; Smelt, A.H.; Westendorp, R.G. 2000: Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. Atherosclerosis 148(2): 413-419
Taepavarapruk, P.; Floresco, S.B.; Phillips, A.G. 2000: Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: Role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology 151(2-3): 242-251
Filip, M.; Cunningham, K.A. 2003: Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex. Journal of Pharmacology and Experimental Therapeutics 306(2): 734-743
Roberts, D.R.D.; Roe, J.; Baudouin, C. 2003: Hyperlordosis as a possible factor in the development of spinal cord infarction. British Journal of Anaesthesia 90(6): 797-800
Mobeireek, A.F.; Joharjy, I.; Mobeireek, A.F. 1998: Hyperlucent lung in a patient with mitral valve disease. Chest 114(5): 1469-1471
Kassubek, J.; Juengling, F.D.; Hellwig, B.; Knauff, M.; Spreer, J.; Lücking, C.H. 2001: Hypermetabolism in the ventrolateral thalamus in unilateral Parkinsonian resting tremor: A positron emission tomography study. Neuroscience Letters 304(1-2): 17-20
Shumake, J.; Edwards, E.; Gonzalez-Lima, F. 2001: Hypermetabolism of paraventricular hypothalamus in the congenitally helpless rat. Neuroscience Letters 311(1): 45-48
Duba, H.C.; Hilbe, W.; Mehringer, A.; Erdel, M.; Thaler, J.; Utermann, G. 2000: Hypermetaphase and interphase fluorescence in situ hybridisation for monitoring of remission status in Philadelphia chromosome positive chronic myeloid leukaemia. International Journal of Oncology 17(6): 1245-1249
Kawakami, K.; Brabender, J.; Lord, R.V.; Groshen, S.; Greenwald, B.D.; Krasna, M.J.; Yin, J.; Fleisher, A.S.; Abraham, J.M.; Beer, D.G.; Sidransky, D.; Huss, H.T.; Demeester, T.R.; Eads, C.; Laird, P.W.; Ilson, D.H.; Kelsen, D.P.; Harpole, D.; Moore, M.B.; Danenberg, K.D.; Danenberg, P.V.; Meltzer, S.J. 2000: Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. Journal of the National Cancer Institute 92(22): 1805-1811
Maass, N.; Biallek, M.; Rösel, F.; Schem, C.; Ohike, N.; Zhang, M.; Jonat, W.; Nagasaki, K. 2002: Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochemical and Biophysical Research Communications 297(1): 125-128
Nagai, H.; Naka, T.; Terada, Y.; Komazaki, T.; Yabe, A.; Jin, E.; Kawanami, O.; Kishimoto, T.; Konishi, N.; Nakamura, M.; Kobayashi, Y.; Emi, M. 2003: Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas. Journal of Human Genetics 48(2): 65-69
Sasaki, M.; Kaneuchi, M.; Fujimoto, S.; Tanaka, Y.; Dahiya, R. 2003: Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Molecular and Cellular Endocrinology 202(1-2): 201-207
Yang, Q.; Sakurai, T.; Yoshimura, G.; Mori, I.; Nakamura, M.; Nakamura, Y.; Suzuma, T.; Tamaki, T.; Umemura, T.; Kakudo, K. 2001: Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma. Anticancer Research 21(3b): 1829-1833
Du, Y.; Carling, T.; Fang, W.; Piao, Z.; Sheu, J.C.; Huang, S. 2001: Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Research 61(22): 8094-8099
Saito, T.; Nishimura, M.; Yamasaki, H.; Kudo, R. 2003: Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Cancer 97(4): 1002-1009
Yuan, Y.; Mendez, R.; Sahin, A.; Dai, J.L. 2001: Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Research 61(14): 5558-5561
Peng, H.; Shen, N.; Qian, L.; Sun, X.L.; Koduru, P.; Goodwin, L.O.; Issa, J.P.; Broome, J.D. 2001: Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells. British Journal of Cancer 85(6): 930-935
Takio, S.; Takase, N.; Satoh, T. 1999: Hypermethylation of CpNpG and CpG sequences flanking telomeres in the liverwort, Marchantia paleacea var. diptera. Journal of Plant Physiology 154(3): 341-345
Melki, J.R.; Vincent, P.C.; Brown, R.D.; Clark, S.J. 2000: Hypermethylation of E-cadherin in leukemia. Blood 95(10): 3208-3213
Rood, B.R.; Zhang, H.; Weitman, D.M.; Cogen, P.H. 2002: Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Research 62(13): 3794-3797
Shibata, D.M.; Sato, F.; Mori, Y.; Perry, K.; Yin, J.; Wang, S.; Xu, Y.; Olaru, A.; Selaru, F.; Spring, K.; Young, J.; Abraham, J.M.; Meltzer, S.J. 2002: Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas. Cancer Research 62(20): 5637-5640
Huang Jianying; Zeng Xianchang; Chen Fei 2000: Hypermethylation of P15 gene in patients with MDS. Hubei Yikedaxue Xuebao 21(2): 130-132
Martinez-Delgado, B.; Richart, A.; García, M.J.; Robledo, M.; Osorio, A.; Cebrian, A.; Rivas, C.; Benitez, J. 2000: Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas. British Journal of Haematology 109(1): 97-103
Kim, D.-H.; Kim, J.S.; Ji, Y.-I.; Shim, Y.M.; Kim, H.; Han, J.; Park, J. 2003: Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Research 63(13): 3743-3746
Byun, D-Sun.; Cho, K.; Ryu, B-Kyu.; Lee, M-Goo.; Kang, M-Ju.; Kim, H-Ryul.; Chi, S-Gil. 2003: Hypermethylation of XIAP-associated factor 1, a putative tumor suppressor gene from the 17p13.2 locus, in human gastric adenocarcinomas. Cancer Research 63(21): 7068-7075
Horikawa, Y.; Sugano, K.; Shigyo, M.; Yamamoto, H.; Nakazono, M.; Fujimoto, H.; Kanai, Y.; Hirohashi, S.; Kakizoe, T.; Habuchi, T.; Kato, T. 2003: Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. Journal of Urology 169(4): 1541-1545
Thomas, X.; Teillon, M.H.; Belhabri, A.; Rimokh, R.; Fiere, D.; Magaud, J.P.; Archimbaud, E. 1999: Hypermethylation of calcitonin gene in adult acute leukemia at diagnosis and during complete remission. Hematology and Cell Therapy 41(1): 19-26
Nakatsuka, S-ichi.; Takakuwa, T.; Tomita, Y.; Hoshida, Y.; Nishiu, M.; Yamaguchi, M.; Nishii, K.; Yang, W-Ick.; Aozasa, K. 2003: Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Science 94(1): 87-91
Chim, C.S.; Liang, R.; Kwong, Y.L. 2002: Hypermethylation of gene promoters in hematological neoplasia. Hematological Oncology 20(4): 167-176
Majumder, S.; Ghoshal, K.; Li, Z.; Jacob, S.T. 1999: Hypermethylation of metallothionein-I promoter and suppression of its induction in cell lines overexpressing the large subunit of Ku protein. Journal of Biological Chemistry 274(40): 28584-28589
Ueki, T.; Toyota, M.; Sohn, T.; Yeo, C.J.; Issa, J.P.; Hruban, R.H.; Goggins, M. 2000: Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Research 60(7): 1835-1839
Guo, S.X.; Taki, T.; Ohnishi, H.; Piao, H.Y.; Tabuchi, K.; Bessho, F.; Hanada, R.; Yanagisawa, M.; Hayashi, Y. 2000: Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leukemia Research 24(1): 39-46
Kurakawa, E.; Shimamoto, T.; Utsumi, K.; Hirano, T.; Kato, H.; Ohyashiki, K. 2001: Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. International Journal of Oncology 19(2): 277-281
Yan, P.S.; Rodriguez, F.J.; Laux, D.E.; Perry, M.R.; Standiford, S.B.; Huang, T.H. 2000: Hypermethylation of ribosomal DNA in human breast carcinoma. British Journal of Cancer 82(3): 514-517
Kito, H.; Suzuki, H.; Ichikawa, T.; Sekita, N.; Kamiya, N.; Akakura, K.; Igarashi, T.; Nakayama, T.; Watanabe, M.; Harigaya, K.; Ito, H. 2001: Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer. Prostate 49(2): 110-115
Klump, B.; Hsieh, C.J.; Holzmann, K.; Gregor, M.; Porschen, R. 1998: Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology 115(6): 1381-1386
Boltze, C.; Zack, S.; Quednow, C.; Bettge, S.; Roessner, A.; Schneider-Stock, R. 2003: Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis. Pathology Research and Practice 199(6): 399-404
Maeda, K.; Kawakami, K.; Ishida, Y.; Ishiguro, K.; Omura, K.; Watanabe, G. 2003: Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. Oncology Reports 10(4): 935-938
Dammann, R.; Yang, G.; Pfeifer, G.P. 2001: Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Research 61(7): 3105-3109
Yoon, J.H.; Dammann, R.; Pfeifer, G.P. 2001: Hypermethylation of the CpG island of the RASSF1A gene in ovarian and renal cell carcinomas. International Journal of Cancer 94(2): 212-217
Katzenellenbogen, R.A.; Baylin, S.B.; Herman, J.G. 1999: Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93(12): 4347-4353
Esteller, M.; Gaidano, G.; Goodman, S.N.; Zagonel, V.; Capello, D.; Botto, B.; Rossi, D.; Gloghini, A.; Vitolo, U.; Carbone, A.; Baylin, S.B.; Herman, J.G. 2002: Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. Journal of the National Cancer Institute 94(1): 26-32
Shannon, B.; Kay, P.; House, A.; Iacopetta, B. 1999: Hypermethylation of the Myf-3 gene in colorectal cancers: Associations with pathological features and with microsatellite instability. International Journal of Cancer 84(2): 109-113
Wang, J.C.; Chen, W.; Nallusamy, S.; Chen, C.; Novetsky, A.D. 2002: Hypermethylation of the P15INK4b and P16INK4a in agnogenic myeloid metaplasia (AMM) and AMM in leukaemic transformation. British Journal of Haematology 116(3): 582-586
Xing, M.; Tokumaru, Y.; Wu, G.; Westra, W.B.; Ladenson, P.W.; Sidransky, D. 2003: Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Research 63(9): 2312-2315
Kato, N.; Tamura, G.; Fukase, M.; Shibuya, H.; Motoyama, T. 2003: Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. American Journal of Pathology 163(2): 387-391
Laux, D.E.; Curran, E.M.; Welshons, W.V.; Lubahn, D.B.; Huang, T.H. 1999: Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas. Breast Cancer Research and Treatment 56(1): 35-43
Roman, J.; Castillejo, J.A.; Jimenez, A.; Bornstein, R.; Gonzalez, M.G.; del Carmen Rodriguez, M.; Barrios, M.; Maldonado, J.; Torres, A. 2001: Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome. British Journal of Haematology 113(2): 329-338
Mouaikel, J.; Verheggen, Céline.; Bertrand, E.; Tazi, J.; Bordonné, Rémy. 2002: Hypermethylation of the cap structure of both yeast sn RNAs and sno RNAs requires a conserved methyltransferase that is localized to the nucleolus. Molecular Cell 9(4): 891-901
Cui, J.; Rohr, L.R.; Swanson, G.; Speights, V.O.; Maxwell, T.; Brothman, A.R. 2001: Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46(3): 249-256
Tang, X.; Khuri, F.R.; Lee, J.J.; Kemp, B.L.; Liu, D.; Hong, W.K.; Mao, L. 2000: Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. Journal of the National Cancer Institute 92(18): 1511-1516
Fleisher, A.S.; Esteller, M.; Wang, S.; Tamura, G.; Suzuki, H.; Yin, J.; Zou, T.T.; Abraham, J.M.; Kong, D.; Smolinski, K.N.; Shi, Y.Q.; Rhyu, M.G.; Powell, S.M.; James, S.P.; Wilson, K.T.; Herman, J.G.; Meltzer, S.J. 1999: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Research 59(5): 1090-1095
Nakayama, M.; Bennett, C.J.; Hicks, J.L.; Epstein, J.I.; Platz, E.A.; Nelson, W.G.; De Marzo, A.M. 2003: Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. American Journal of Pathology 163(3): 923-933
Guilleret, I.; Yan, P.; Grange, F.; Braunschweig, R.; Bosman, F.T.; Benhattar, J. 2002: Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity. International Journal of Cancer 101(4): 335-341
Kuerbitz, S.J.; Pahys, J.; Wilson, A.; Compitello, N.; Gray, T.A. 2002: Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia. Carcinogenesis 23(4): 559-564
Schmitt, J.F.; Millar, D.S.; Pedersen, J.S.; Clark, S.L.; Venter, D.J.; Frydenberg, M.; Molloy, P.L.; Risbridger, G.P. 2002: Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. Molecular Endocrinology 16(2): 213-220
Horan, M.P.; Cooper, D.N.; Upadhyaya, M. 2000: Hypermethylation of the neurofibromatosis type 1 (NF1) gene promoter is not a common event in the inactivation of the NF1 gene in NF1-specific tumours. Human Genetics 107(1): 33-39
Sato, F.; Harpaz, N.; Shibata, D.; Xu, Y.; Yin, J.; Mori, Y.; Zou, T.-T.; Wang, S.; Desai, K.; Leytin, A.; Selaru, F.M.; Abraham, J.M.; Meltzer, S.J. 2002: Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Research 62(4): 1148-1151
Chen, H.; Wu, S. 2002: Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes. Chinese Medical Journal 115(7): 987-990
Liang, J.T.; Chang, K.J.; Chen, J.C.; Lee, C.C.; Cheng, Y.M.; Hsu, H.C.; Wu, M.S.; Wang, S.M.; Lin, J.T.; Cheng, A.L. 1999: Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival. Oncology 57(2): 149-156
Simpson, D.J.; Bicknell, J.E.; McNicol, A.M.; Clayton, R.N.; Farrell, W.E. 1999: Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas. Genes Chromosomes and Cancer 24(4): 328-336
Wheeler, J.M.; Kim, H.C.; Efstathiou, J.A.; Ilyas, M.; Mortensen, N.J.; Bodmer, W.F. 2001: Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48(3): 367-371
Santourlidis, S.; Warskulat, U.; Florl, A.R.; Maas, S.; Pulte, T.; Fischer, J.; Müller, W.; Schulz, W.A. 2001: Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma. Molecular Carcinogenesis 32(1): 36-43
Chung, W.B.; Hong, S.H.; Kim, J.A.; Sohn, Y.K.; Kim, B.W.; Kim, J.W. 2001: Hypermethylation of tumor-related genes in genitourinary cancer cell lines. Journal of Korean Medical Science 16(6): 756-761
Huang, Y.; de la Chapelle, A.; Pellegata, N.S. 2003: Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. International Journal of Cancer 104(6): 735-744
Esteller, M.; Tortola, S.; Toyota, M.; Capella, G.; Peinado, M.A.; Baylin, S.B.; Herman, J.G. 2000: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Research 60(1): 129-133
Esteller, M.; Guo, M.; Moreno, V.; Peinado, M.A.; Capella, G.; Galm, O.; Baylin, S.B.; Herman, J.G. 2002: Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Research 62(20): 5902-5905
Garinis, G.A.; Menounos, P.G.; Spanakis, N.E.; Papadopoulos, K.; Karavitis, G.; Parassi, I.; Christeli, E.; Patrinos, G.P.; Manolis, E.N.; Peros, G. 2002: Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. Journal of Pathology 198(4): 442-449
Yan, P.; Mühlethaler, A.; Bourloud, K.B.; Beck, M.N.; Gross, N. 2003: Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma. Genes Chromosomes and Cancer 36(2): 129-138
van Dongen, P.W.; de Boer, M.; Lemmens, W.A.; Theron, G.B. 1999: Hypermobility and peripartum pelvic pain syndrome in pregnant South African women. European Journal of Obstetrics Gynecology and Reproductive Biology 84(1): 77-82
Grahame, R.; Bird, H. 2003: Hypermobility in New Zealand. Rheumatology 42(3): 491; Author Reply 491-2
Bai, Y.; Fox, D.T.; Lacy, J.A.; Van Lanen, S.G.; Iwata-Reuyl, D. 2000: Hypermodification of tRNA in Thermophilic archaea. Cloning, overexpression, and characterization of tRNA-guanine transglycosylase from Methanococcus jannaschii. Journal of Biological Chemistry 275(37): 28731-28738
Bacon, A.L.; Dunlop, M.G.; Farrington, S.M. 2001: Hypermutability at a poly(A/T) tract in the human germline. Nucleic Acids Research 29(21): 4405-4413
Xu, X.S.; Narayanan, L.; Dunklee, B.; Liskay, R.M.; Glazer, P.M. 2001: Hypermutability to ionizing radiation in mismatch repair-deficient, Pms2 knockout mice. Cancer Research 61(9): 3775-3780
Wright, B.E.; Reimers, J.M.; Schmidt, K.H.; Reschke, D.K. 2002: Hypermutable bases in the p53 cancer gene are at vulnerable positions in DNA secondary structures. Cancer Research 62(20): 5641-5644
Sugita, T.; Hiwasa, T.; Nomura, J.; Kita, K.; Hiroshima, K.; Suzuki, H.; Sekiya, S.; Suzuki, N. 2001: Hypermutable change of human UV(r)-1 cells by p53 overexpression. Biochemical and Biophysical Research Communications 289(3): 756-762
Bois, P.R.J. 2003: Hypermutable minisatellites, a human affair?. Genomics 81(4): 349-355
Bucci, C.; Lavitola, A.; Salvatore, P.; Del Giudice, L.; Massardo, D.R.; Bruni, C.B.; Alifano, P. 1999: Hypermutation in pathogenic bacteria: Frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Molecular Cell 3(4): 435-445
Lee, S.S.; Tranchina, D.; Ohta, Y.; Flajnik, M.F.; Hsu, E. 2002: Hypermutation in shark immunoglobulin light chain genes results in contiguous substitutions. Immunity 16(4): 571-582
Lombardo, M.J.; Rosenberg, S.M. 1999: Hypermutation in stationary-phase E. coli: Tales from the lac operon. Journal of Genetics 78(1): 13-20
Habermann, W.; Kiesler, K.; Dornbusch, H.J.; Friedrich, G. 2000: Hypernasality--a rare initial symptom of a cerebellar astrocytoma. International Journal of Pediatric Otorhinolaryngology 55(3): 207-210
Usalan, C.; Altun, B.; Ulusoy, S.; Erdem, Y.; Yasavul, U.; Turgan, C.; Cağlar, S. 1999: Hypernatraemia and polyuria due to high-dose colchicine in a suicidal patient. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(6): 1556-1557
Amirlak, I.; Dawson, K. 2000: Hypernatraemia in early infancy. Annals of Tropical Paediatrics 20(3): 173-7; Discussion 177-8
Harding, D.; Cairns, P.; Gupta, S.; Cowan, F. 2001: Hypernatraemia: why bother weighing breast fed babies?. Archives of Disease in Childhood. Fetal and Neonatal Edition 85(2): F145
Oddie, S.; Richmond, S.; Coulthard, M. 2001: Hypernatraemic dehydration and breast feeding: a population study. Archives of Disease in Childhood 85(4): 318-320
Handy, T.C.; Hanzlick, R.; Shields, L.B.; Reichard, R.; Goudy, S. 1999: Hypernatremia and subdural hematoma in the pediatric age group: is there a causal relationship?. Journal of Forensic Sciences 44(6): 1114-1118
Kavelaars, J.; Tamsma, J.T.; Meinders, A.E. 2001: Hypernatremia in a non insulin dependent (type 2) diabetic patient with central diabetes insipidus. Netherlands Journal of Medicine 58(3): 150-154
Kahn, T. 1999: Hypernatremia with edema. Archives of Internal Medicine 159(1): 93-98
Berendes, K.; Glass, W.; Warmke, C. 2001: Hypernatriaemie als seltene Komplikation bei Umstellung von Lithium auf Valproat. Nervenarzt 72(7): 555-557
Kawahara, K.; Watanabe, S.; Ohshima, T.; Soejima, Y.; Oishi, T.; Aratani, S.; Nakata, M.; Shibata, M.; Inoue, K.; Amano, T.; Fujii, R.; Yanai, K.; Hagiwara, M.; Fukamizu, A.; Maruyama, I.; Nakajima, T. 1999: Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells. Biochemical and Biophysical Research Communications 266(2): 417-424
Zadok, D.; Maskaleris, G.; Montes, M.; Shah, S.; Garcia, V.; Chayet, A. 2000: Hyperopic laser in situ keratomileusis with the Nidek EC-5000 excimer laser. Ophthalmology 107(6): 1132-1137
Francesconi, Cáudia.M.; Nosé, R.A.M.; Nosé, W. 2002: Hyperopic laser-assisted in situ keratomileusis for radial keratotomy induced hyperopia. Ophthalmology 109(3): 602-605
Terada, Y.; Inoshita, S.; Hanada, S.; Shimamura, H.; Kuwahara, M.; Ogawa, W.; Kasuga, M.; Sasaki, S.; Marumo, F. 2001: Hyperosmolality activates Akt and regulates apoptosis in renal tubular cells. Kidney International 60(2): 553-567
Massett, M.P.; Koller, A.; Kaley, G. 2000: Hyperosmolality dilates rat skeletal muscle arterioles: role of endothelial K(ATP) channels and daily exercise. Journal of Applied Physiology 89(6): 2227-2234
Kramer, H.J.; Hashemi, T.; Bäcker, A.; Bokemeyer, D. 2002: Hyperosmolality induced by betaine or urea stimulates endothelin synthesis by differential activation of ERK and p38 MAP kinase in MDCK cells. Kidney and Blood Pressure Research 25(2): 65-70
Zhuang, S.; Hirai, S.I.; Ohno, S. 2000: Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells. American Journal of Physiology. Cell Physiology 278(1): C102-C109
Mattei, C.; Molgó, J.; Marquais, M.; Vernoux, J.; Benoit, E. 1999: Hyperosmolar D-mannitol reverses the increased membrane excitability and the nodal swelling caused by Caribbean ciguatoxin-1 in single frog myelinated axons. Brain Research 847(1): 50-58
Chedru, V.; Aujoulat, O.; Beck Wirth, G. 1998: Hyperosmolar coma and protease inhibitors. Journal de Pharmacie Clinique 17(3): 178-179
Yildiz, M.; Gül, C.; Ozbay, Gültaç. 2002: Hyperosmolar hyperglycaemic nonketotic coma associated with acute myocardial infarction: report of three cases. Acta Cardiologica 57(4): 271-274
Liamis, G.; Gianoutsos, C.; Elisaf, M.S. 2000: Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?. Diabetes and Metabolism 26(5): 403-405
Högman, M.; Hageman, C.; Hua, X. 1999: Hyperosmolar saline induces airway resistance changes and neuropeptide release: A comparison with the effect of capsaicin, potassium and histamine. European Journal of Clinical Investigation 29(3): 264-269
Sanico, A.M.; Philip, G.; Lai, G.K.; Togias, A. 1999: Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. Journal of Applied Physiology 86(4): 1202-1210
Kishioka, C.; Okamoto, K.; Kim, J-Soo.; Rubin, B.K. 2003: Hyperosmolar solutions stimulate mucus secretion in the ferret trachea. Chest 124(1): 306-313
Reinehr, R.; Schliess, F.; Häussinger, D. 2003: Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 17(6): 731-733
Winkler, B.S. 2003: Hyperosmolarity and electroretinogram (ERG) potentials in isolated rat retinas: Possible implications in diabetic models. Experimental Eye Research 77(1): 115-116
Hjoberg, J.; Högman, M.; Hedenstierna, G. 2003: Hyperosmolarity decreases the relaxing potency of sodium nitroprusside on guinea-pig trachea by the release of superoxide anions. Acta Physiologica Scandinavica 178(3): 279-283
Safdar, Z.; Wang, P.; Ichimura, H.; Issekutz, A.C.; Quadri, S.; Bhattacharya, J. 2003: Hyperosmolarity enhances the lung capillary barrier. Journal of Clinical Investigation 112(10): 1541-1549
Li, D.; Randhawa, V.K.; Patel, N.; Hayashi, M.; Klip, A. 2001: Hyperosmolarity reduces GLUT4 endocytosis and increases its exocytosis from a VAMP2-independent pool in l6 muscle cells. Journal of Biological Chemistry 276(25): 22883-22891
Bykhovskaia, M.; Polagaeva, E.; Hackett, J.T. 2001: Hyperosmolarity reduces facilitation by a Ca(2+)-independent mechanism at the lobster neuromuscular junction: possible depletion of the releasable pool. Journal of Physiology 537(Pt 1): 179-190
Reinehr, R.; Graf, D.; Fischer, R.; Schliess, F.; Häussinger, D. 2002: Hyperosmolarity triggers CD95 membrane trafficking and sensitizes rat hepatocytes toward CD95L-induced apoptosis. Hepatology 36(3): 602-614
Hashimoto, S.; Matsumoto, K.; Gon, Y.; Nakayama, T.; Takeshita, I.; Horie, T. 1999: Hyperosmolarity-induced interleukin-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase. American Journal of Respiratory and Critical Care Medicine 159(2): 634-640
Hjoberg, J.; Folkerts, G.; van Gessel, S.B.; Högman, M.; Hedenstierna, G.; Nijkamp, F.P. 2000: Hyperosmolarity-induced relaxation and prostaglandin release in guinea pig trachea in vitro. European Journal of Pharmacology 398(2): 303-307
Odland, R.M.; Sutton, R.L. 1999: Hyperosmosis of cerebral injury. Neurological Research 21(5): 500-508
Leroy, C.; Basset, G.; Gruel, G.; Ripoche, P.; Trinh-Trang-Tan, M.M.; Rousselet, G. 2000: Hyperosmotic NaCl and urea synergistically regulate the expression of the UT-A2 urea transporter in vitro and in vivo. Biochemical and Biophysical Research Communications 271(2): 368-373
Kim, Y.A.; Akoev, V.R.; Elemesov, R.E. 2000: Hyperosmotic hemolysis and antihemolytic activity of saponin fraction and triterpenoidal glycosides from Panax ginseng C.A. Meyer. Biologicheskie Membrany 17(2): 188-199
Falck, G.; Schjøtt, J.; Bruvold, M.; Krane, J.; Skarra, S.; Jynge, P. 2000: Hyperosmotic perfusion of the beating rat heart and the role of the Na+/K+/2Cl- co-transporter and the Na+/H+ exchanger. Basic Research in Cardiology 95(1): 19-27
Lee, M.S.; Lee, G.M. 2000: Hyperosmotic pressure enhances immunoglobulin transcription rates and secretion rates of KR12H-2 transfectoma. Biotechnology and Bioengineering 68(3): 260-268
Barros, L.F.; Barnes, K.; Ingram, J.C.; Castro, J.; Porras, O.H.; Baldwin, S.A. 2001: Hyperosmotic shock induces both activation and translocation of glucose transporters in mammalian cells. Pflugers Archiv: European Journal of Physiology 442(4): 614-621
Bianchi, A.A.; Baneyx, F. 1999: Hyperosmotic shock induces the sigma32 and sigmaE stress regulons of Escherichia coli. Molecular Microbiology 34(5): 1029-1038
Ochi, H.; Masuda, J.; Gimbrone, M.A. 2002: Hyperosmotic stimuli inhibit VCAM-1 expression in cultured endothelial cells via effects on interferon regulatory factor-1 expression and activity. European Journal of Immunology 32(7): 1821-1831
Di Ciano-Oliveira, C.; Sirokmány, G.áb.; Szászi, K.; Arthur, W.T.; Masszi, A.ás.; Peterson, M.; Rotstein, O.D.; Kapus, A.ás. 2003: Hyperosmotic stress activates Rho: differential involvement in Rho kinase-dependent MLC phosphorylation and NKCC activation. American Journal of Physiology. Cell Physiology 285(3): C555-C566
Ouwens, D.M.; Gomes de Mesquita, D.S.; Dekker, J.; Maassen, J.A. 2001: Hyperosmotic stress activates the insulin receptor in CHO cells. Biochimica et Biophysica Acta 1540(2): 97-106
Schmelzer, A.E.; Miller, W.M. 2002: Hyperosmotic stress and elevated pCO2 alter monoclonal antibody charge distribution and monosaccharide content. Biotechnology Progress 18(2): 346-353
Takahashi, S.; Katagiri, T.; Hirayama, T.; Yamaguchi-Shinozaki, K.; Shinozaki, K. 2001: Hyperosmotic stress induces a rapid and transient increase in inositol 1,4,5-trisphosphate independent of abscisic acid in Arabidopsis cell culture. Plant and Cell Physiology 42(2): 214-222
Németh, Z.án.H.; Deitch, E.A.; Szabó, C.; Haskó, G.ör. 2002: Hyperosmotic stress induces nuclear factor-kappaB activation and interleukin-8 production in human intestinal epithelial cells. American Journal of Pathology 161(3): 987-996
Rodríguez, I.; Kaszkin, M.; Holloschi, A.; Kabsch, K.; Marqués, M.M.; Mao, X.; Alonso, A. 2002: Hyperosmotic stress induces phosphorylation of cytosolic phospholipase A(2) in HaCaT cells by an epidermal growth factor receptor-mediated process. Cellular Signalling 14(10): 839-848
Meijer, H.J.G.; Divecha, N.; Van Den Ende, H.; Musgrave, A.; Munnik, T. 1999: Hyperosmotic stress induces rapid synthesis of phosphatidyl-D-inositol 3,5-bisphosphate in plant cells. Planta (Berlin) 208(2): 294-298
Gual, P.; Gonzalez, T.; Grémeaux, T.; Barres, R.; Le Marchand-Brustel, Y.; Tanti, J.-F.ço. 2003: Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes. Journal of Biological Chemistry 278(29): 26550-26557
Meijer, H.J.; Arisz, S.A.; Van Himbergen, J.A.; Musgrave, A.; Munnik, T. 2001: Hyperosmotic stress rapidly generates lyso-phosphatidic acid in Chlamydomonas. Plant journal: for cell and molecular biology 25(5): 541-548
Alonso-Monge, R.; Real, E.; Wojda, I.; Bebelman, J.P.; Mager, W.H.; Siderius, M. 2001: Hyperosmotic stress response and regulation of cell wall integrity in Saccharomyces cerevisiae share common functional aspects. Molecular Microbiology 41(3): 717-730
Bell, L.M.; Leong, M.L.; Kim, B.; Wang, E.; Park, J.; Hemmings, B.A.; Firestone, G.L. 2000: Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38 MAPK-dependent pathway. Journal of Biological Chemistry 275(33): 25262-25272
Aizawa, H.; Katadae, M.; Maruya, M.; Sameshima, M.; Murakami-Murofushi, K.; Yahara, I. 1999: Hyperosmotic stress-induced reorganization of actin bundles in Dictyostelium cells over-expressing cofilin. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 4(6): 311-324
Deaton, L.E.. 2001: Hyperosmotic volume regulation in the gills of the ribbed mussel, Geukensia demissa: Rapid accumulation of betaine and alanine. Journal of Experimental Marine Biology and Ecology 260(2): 185-197
Torbett, N.E.; Casamassima, A.; Parker, P.J. 2003: Hyperosmotic-induced protein kinase N 1 activation in a vesicular compartment is dependent upon Rac1 and 3-phosphoinositide-dependent kinase 1. Journal of Biological Chemistry 278(34): 32344-32351
Pritchard, S.; Erickson, G.R.; Guilak, F. 2002: Hyperosmotically induced volume change and calcium signaling in intervertebral disk cells: the role of the actin cytoskeleton. Biophysical Journal 83(5): 2502-2510
Pieper, D.R.; Al-Mefty, O.; Hanada, Y.; Buechner, D. 1999: Hyperostosis associated with meningioma of the cranial base: secondary changes or tumor invasion. Neurosurgery 44(4): 742
Wolf, D.A.; Falsetti, A.B. 2001: Hyperostosis cranii ex vacuo in adults: a consequence of brain atrophy from diverse causes. Journal of Forensic Sciences 46(2): 370-373
Hershkovitz, I.; Greenwald, C.; Rothschild, B.M.; Latimer, B.; Dutour, O.; Jellema, L.M.; Wish-Baratz, S. 1999: Hyperostosis frontalis interna: an anthropological perspective. American Journal of Physical Anthropology 109(3): 303-325
Frater, J. 2001: Hyperostotic polyarthropathy in a rabbit--a suspected case of chronic hypervitaminosis A from a diet of carrots. Australian Veterinary Journal 79(9): 608-611
Monico, C.G.; Milliner, D.S. 1999: Hyperoxaluria and urolithiasis in young children: an atypical presentation. Journal of Endourology 13(9): 633-636
Mehler, K.; Stapenhorst, L.; Beck, B.; Hoppe, B. 2003: Hyperoxaluria in patients with primary distal renal tubular acidosis. Pediatric Nephrology 18(7): 722-723
Lawas-Alejo, P.A.; Slivka, S.; Hernandez, H.; Bry, K.; Hallman, M. 1999: Hyperoxia and glucocorticoid modify retinal vessel growth and interleukin-1 receptor antagonist in newborn rabbits. Pediatric Research 45(3): 313-317
van Golde, J.M.; Mulder, T.A.; Scheve, E.; Prinzen, F.W.; Blanco, C.E. 1999: Hyperoxia and local organ blood flow in the developing chick embryo. Journal of Physiology 515: 243-248
Bhandari, V.; Johnson, L.; Smith-Kirwin, S.; Vigliotta, G.; Funanage, V.; Chander, A. 2002: Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type Ii pneumocytes. Lung 180(6): 301-317
Novotná, J.; Bíbová, J.; Hampl, V.; Deyl, Z.; Herget, J. 2001: Hyperoxia and recovery from hypoxia alter collagen in peripheral pulmonary arteries similarly. Physiological Research 50(2): 153-163
Johnston, A.J.; Steiner, L.A.; Balestreri, M.; Gupta, A.K.; Menon, D.K. 2003: Hyperoxia and the cerebral hemodynamic responses to moderate hyperventilation. Acta Anaesthesiologica Scandinavica 47(4): 391-396
Rehan, V.; Torday, J. 2003: Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochemistry and Biophysics 38(3): 239-250
Wang, L.; Osborne, P.G.; Yu, X.; Shangguan, D.; Zhao, R.; Han, H.; Liu, G. 2003: Hyperoxia caused by microdialysis perfusion decreased striatal monoamines: Involvement of oxidative stress. Neurochemistry International 42(6): 465-470
Bhandari, V.; Maulik, N.; Kresch, M. 2000: Hyperoxia causes an increase in antioxidant enzyme activity in adult and fetal rat type II pneumocytes. Lung 178(1): 53-60
Yamada, H.; Yamada, E.; Hackett, S.F.; Ozaki, H.; Okamoto, N.; Campochiaro, P.A. 1999: Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. Journal of Cellular Physiology 179(2): 149-156
Hoehn, T.; Felderhoff-Mueser, U.; Maschewski, K.; Stadelmann, C.; Sifringer, M.; Bittigau, P.; Koehne, P.; Hoppenz, M.; Obladen, M.; Bührer, C. 2003: Hyperoxia causes inducible nitric oxide synthase-mediated cellular damage to the immature rat brain. Pediatric Research 54(2): 179-184
Pedersen, P.K.; Kiens, B.; Saltin, B. 1999: Hyperoxia does not increase peak muscle oxygen uptake in small muscle group exercise. Acta Physiologica Scandinavica 166(4): 309-318
O'Reilly, P.J.; Hickman-Davis, J.M.; Davis, I.C.; Matalon, S. 2003: Hyperoxia impairs antibacterial function of macrophages through effects on actin. American Journal of Respiratory Cell and Molecular Biology 28(4): 443-450
Eves, N.D.; Petersen, S.R.; Jones, R.L. 2002: Hyperoxia improves maximal exercise with the self-contained breathing apparatus (SCBA). Ergonomics 45(12): 829-839
Hughes, S.J.; Davies, S.E.; Powis, S.H.; Press, M. 2003: Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Transplantation 75(12): 1954-1959
Habler, O.; Kleen, M.; Kemming, G.; Zwissler, B. 2002: Hyperoxia in extreme hemodilution. European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes 34(1-2): 181-187
Tong, L.; Toliver-Kinsky, T.; Rassin, D.; Werrbach-Perez, K.; Perez-Polo, J.Regino. 2003: Hyperoxia increases AP-1 DNA binding in rat brain. Neurochemical Research 28(1): 111-115
Hosford, G.E.; Koyanagi, K.S.; Leung, W.I.; Olson, D.M. 2002: Hyperoxia increases protein mass of 5-lipoxygenase and its activating protein, flap, and leukotriene B(4) output in newborn rat lungs. Experimental Lung Research 28(8): 671-684
Jones, N.; Agani, F.H. 2003: Hyperoxia induces Egr-1 expression through activation of extracellular signal-regulated kinase 1/2 pathway. Journal of Cellular Physiology 196(2): 326-333
Nyunoya, T.; Powers, L.S.; Yarovinsky, T.O.; Butler, N.S.; Monick, M.M.; Hunninghake, G.W. 2003: Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. Journal of Biological Chemistry 278(38): 36099-36106
Gu, X.; El-Remessy, A.B.; Brooks, S.E.; Al-Shabrawey, M.; Tsai, N-Tsi.; Caldwell, R.B. 2003: Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. American Journal of Physiology. Cell Physiology 285(3): C546-C554
Franek, W.R.; Horowitz, S.; Stansberry, L.; Kazzaz, J.A.; Koo, H.C.; Li, Y.; Arita, Y.; Davis, J.M.; Mantell, A.S.; Scott, W.; Mantell, L.L. 2001: Hyperoxia inhibits oxidant-induced apoptosis in lung epithelial cells. Journal of Biological Chemistry 276(1): 569-575
Rancourt, R.C.; Staversky, R.J.; Keng, P.C.; O'Reilly, M.A. 1999: Hyperoxia inhibits proliferation of Mv1Lu epithelial cells independent of TGF-beta signaling. American Journal of Physiology 277(6): L1172-L1178
Eynan, M.; Arieli, Y.; Arieli, R.; Bomzon, A. 2003: Hyperoxia may reduce energetic efficiency in the trained rat. Aviation Space and Environmental Medicine 74(10): 1029-1033
Kashikura, K.; Kershaw, J.; Kashikura, A.; Zhang, X.; Matsuura, T.; Kanno, I. 2001: Hyperoxia modified activation-induced blood oxygenation level-dependent response of human visual cortex (V1): An event-related functional magnetic resonance imaging study. Neuroscience Letters 299(1-2): 53-56
Allen, G.L.; Menendez, I.Y.; Ryan, M.A.; Mazor, R.L.; Wispé, J.R.; Fiedler, M.A.; Wong, H.R. 2000: Hyperoxia synergistically increases TNF-alpha-induced interleukin-8 gene expression in A549 cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 278(2): L253-L260
Kashikura, K.; Kershaw, J.; Kashikura, A.; Matsuura, T.; Kanno, I. 2000: Hyperoxia-enhanced activation-induced hemodynamic response in human VI: an fMRi study. Neuroreport 11(5): 903-906
Parinandi, N., L.; Kleinberg, M., A.; Usatyuk, P., V.; Cummings, R., J.; Pennathur, A.; Cardounel, A., J.; Zweier, J., L.; Garcia, J., G.N.; Natarajan, V. 2003: Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. American Journal of Physiology 284(1 Part 1): L26-L38
Budinger, G.R.S.; Tso, M.; McClintock, D.S.; Dean, D.A.; Sznajder, J.I.; Chandel, N.S. 2002: Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. Journal of Biological Chemistry 277(18): 15654-15660
Ichikado, K.; Suga, M.; Gushima, Y.; Johkoh, T.; Iyonaga, K.; Yokoyama, T.; Honda, O.; Shigeto, Y.; Tomiguchi, S.; Takahashi, M.; Itoh, H.; Ikezoe, J.; Müller, N.L.; Ando, M. 2000: Hyperoxia-induced diffuse alveolar damage in pigs: correlation between thin-section CT and histopathologic findings. Radiology 216(2): 531-538
Lonchampt, M.; Pennel, L.; Duhault, J. 2001: Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II. IOVS Investigative Ophthalmology and Visual Science 42(2): 429-432
Irwin, S.; Davenport, J. 2002: Hyperoxic boundary layers inhabited by the epiphytic meiofauna of Fucus serratus. ine Ecology Progress Series ember 29; 244: 73-79
Butler, F.K.; White, E.; Twa, M. 1999: Hyperoxic myopia in a closed-circuit mixed-gas scuba diver. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 26(1): 41-45
Zwemer, C.F.; Shoemaker, J.L.; Hazard, S.W.; Davis, R.E.; Bartoletti, A.G.; Phillips, C.L. 2000: Hyperoxic reperfusion exacerbates postischemic renal dysfunction. Surgery 128(5): 815-821
Liu, Z.; Yu, R. 1998: Hyperoxic-induced change in ventilation: Ventilatory drive and hypercapnia in patients with COPD. Journal of China Medical University 27(5): 462-466
Oliveira, L.; Tavares, J.; Vieira, V. 1998: Hyperparasites of Apanteles militaris (Hymenoptera: Braconidae) at S. Miguel Island (Azores). Boletim do Museu Municipal do Funchal 1998(Suppl 5 Part B): 283-289
Huebner, G.; Dettner, K. 2000: Hyperparasitoid defense strategies against spiders: The role of chemical and morphological protection. Entomologia Experimentalis et Applicata 97(1): 67-74
Yuan Xiu Ying; Han Yan Jie 2000: Hyperparastism and biocontrol of Hedysarum mongolicum rust by Sphaerellopsis filum. Forest Research 13(1): 103-106
Hertig, A.; Maruani, G.; Paillard, M.; Houillier, P. 2000: Hyperparathyroidie primitive. Nephrologie 21(6): 283-290
Gallieni, M.; Corsi, C.; Brancaccio, D. 2000: Hyperparathyroidism and anemia in renal failure. American Journal of Nephrology 20(2): 89-96
Chertow, G.M.; Plone, M.; Dillon, M.A.; Burke, S.K.; Slatopolsky, E. 2000: Hyperparathyroidism and dialysis vintage. Clinical Nephrology 54(4): 295-300
Bresler, S.A.; Logan, W.S.; Washington, D. 2000: Hyperparathyroidism and psychosis: possible prelude to murder. Journal of Forensic Sciences 45(3): 728-730
Pickard, A.L.; Gridley, G.; Mellemkjae, L.; Johansen, C.; Kofoed-Enevoldsen, A.; Cantor, K.P.; Brinton, L.A. 2002: Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer 95(8): 1611-1617
Berruti, A.; Dogliotti, L.; Tucci, M.; Scarpa, R.Mario.; Angeli, A. 2002: Hyperparathyroidism due to the so-called bone hunger syndrome in prostate cancer patients. Journal of clinical endocrinology and metabolism 87(4): 1910-1; author reply 1911
Picca, S.; Cappa, M.; Rizzoni, G. 2000: Hyperparathyroidism during growth hormone treatment: A role for puberty?. Pediatric Nephrology 14(1): 56-58
Marx, S.J.; Simonds, W.F.; Agarwal, S.K.; Burns, A.Lee.; Weinstein, L.S.; Cochran, C.; Skarulis, M.C.; Spiegel, A.M.; Libutti, S.K.; Alexander, H.Richard.; Chen, C.C.; Chang, R.; Chandrasekharappa, S.C.; Collins, F.S. 2002: Hyperparathyroidism in hereditary syndromes: special expressions and special managements. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 17(Suppl): N37-N43
Chen, J.D.; Morrison, C.; Zhang, C.; Kahnoski, K.; Carpten, J.D.; Teh, B.T. 2003: Hyperparathyroidism-jaw tumour syndrome. Journal of Internal Medicine 253(6): 634-642
Albertazzi, P.; Steel, S.A.; Purdie, D.W.; Gurney, E.; Atkin, S.L.; Robertson, W.Stuart. 2002: Hyperparathyroidism in elderly osteopenic women. Maturitas 43(4): 245-249
Adachi, N.; Watanabe, T.; Matsuda, H.; Onuma, T. 2000: Hyperperfusion in the lateral temporal cortex, the striatum and the thalamus during complex visual hallucinations: single photon emission computed tomography findings in patients with Charles Bonnet syndrome. Psychiatry and Clinical Neurosciences 54(2): 157-162
Schindler, K.; Gast, H.; Bassetti, C.; Wiest, R.; Fritschi, J.; Meyer, K.; Kollar, M.; Wissmeyer, M.; Lövblad, K.; Weder, B.; Donati, F. 2001: Hyperperfusion of anterior cingulate gyrus in a case of paroxysmal nocturnal dystonia. Neurology 57(5): 917-920
Bando, K.; Satoh, K.; Matsubara, S.; Nakatani, M.; Nagahiro, S. 2001: Hyperperfusion phenomenon after percutaneous transluminal angioplasty for atherosclerotic stenosis of the intracranial vertebral artery. Case report. Journal of Neurosurgery 94(5): 826-830
Liu, A.Y.; Do, H.M.; Albers, G.W.; Lopez, J.R.; Steinberg, G.K.; Marks, M.P. 2001: Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. Ajnr. American Journal of Neuroradiology 22(8): 1597-1601
Smith, M.; Cros, D.; Sheen, V. 2002: Hyperperfusion with vasogenic leakage by fMRi in migraine with prolonged aura. Neurology 58(8): 1308-1310
Pfefferkorn, T.; Mayer, T.; Von Stuckrad-Barre, S.; Covi, M.; Hamann, G.F. 2001: Hyperperfusion-induced intracerebral hemorrhage after carotid stenting documented by TCD. Neurology 57(10): 1933-1935
Martinez, A.; Kastner, B.; Taeusch, H.W. 1999: Hyperphagia in neonates withdrawing from methadone. Archives of Disease in Childhood. Fetal and Neonatal Edition 80(3): F178-F182
Williams, C.M.; Rogers, P.J.; Kirkham, T.C. 1998: Hyperphagia in pre-fed rats following oral delta9-THC. Physiology and Behavior 65(2): 343-346
Weide, K.; Christ, N.; Moar, K.M.; Arens, J.; Hinney, A.; Mercer, J.G.; Eiden, S.; Schmidt, I. 2003: Hyperphagia, not hypometabolism, causes early onset obesity in melanocortin-4 receptor knockout mice. Physiological Genomics 13(1): 47-56
Polidori, C.; Gentili, F.; Pigini, M.; Quaglia, W.; Panocka, I.; Massi, M. 2000: Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites. European Journal of Pharmacology 392(1-2): 41-49
Faulconbridge, L.F.; Cummings, D.E.; Kaplan, J.M.; Grill, H.J. 2003: Hyperphagic effects of brainstem ghrelin administration. Diabetes 52(9): 2260-2265
Ayling, J.E.; Bailey, S.W.; Boerth, S.R.; Giugliani, R.; Braegger, C.P.; Thöny, B.; Blau, N. 2000: Hyperphenylalaninemia and 7-pterin excretion associated with mutations in 4a-hydroxy-tetrahydrobiopterin dehydratase/DCoH: analysis of enzyme activity in intestinal biopsies. Molecular Genetics and Metabolism 70(3): 179-188
Bianca, S.; Meli, C.; Barrano, B.; Mollica, F. 2002: Hyperphenylalaninemia and birth weight. Annales de Genetique 45(3): 105-107
Bayle, J.H.; Randazzo, F.; Johnen, G.; Kaufman, S.; Nagy, A.; Rossant, J.; Crabtree, G.R. 2002: Hyperphenylalaninemia and impaired glucose tolerance in mice lacking the bifunctional DCoH gene. Journal of Biological Chemistry 277(32): 28884-28891
Costabeber, E.; Kessler, A.; Severo Dutra-Filho, C.; de Souza Wyse, A.Terezinha.; Wajner, M.; Wannmacher, Cóvis.Milton.Duval. 2003: Hyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 21(2): 111-116
Cizman, B. 2003: Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 18(Suppl 5): V47-V49
Cannata-Andía, J.B.; Rodríguez-García, M. 2002: Hyperphosphataemia as a cardiovascular risk factor -- how to manage the problem. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 17(Suppl 11): 16-19
Amann, K.; Gross, M.L.; London, G.M.; Ritz, E. 1999: Hyperphosphataemia--a silent killer of patients with renal failure?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(9): 2085-2087
Amann, K.; Törnig, J.; Kugel, B.; Gross, M.-L.; Tyralla, K.; El-Shakmak, A.; Szabo, A.ás.; Ritz, E. 2003: Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney International 63(4): 1296-1301
Bachelder, V.D.; Muehlstedt, S.G.; Smith, C.L. 2001: Hyperphosphatemia in a burn patient. Journal of Burn Care and Rehabilitation 22(2): 187-9; discussion 186-7
Llach, F. 1999: Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences. Kidney International Suppl 1999(73): S 31-S 37
Jara, A.; Chacón, C.; Felsenfeld, A.J. 2002: Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats. Nephron 92(4): 883-888
Malluche, H.H.; Monier-Faugère, M.C. 2000: Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow. Clinical Nephrology 54(4): 309-317
Carty, S.M.; Greenleaf, A.L. 2002: Hyperphosphorylated C-terminal repeat domain-associating proteins in the nuclear proteome link transcription to DNA/chromatin modification and RNA processing. Molecular and Cellular Proteomics: Mcp 1(8): 598-610
Härtig, W.; Klein, C.; Brauer, K.; Schüppel, K.F.; Arendt, T.; Bigl, V.; Brückner, G. 2001: Hyperphosphorylated protein tau is restricted to neurons devoid of perineuronal nets in the cortex of aged bison. Neurobiology of Aging 22(1): 25-33
Zhong, J.; Iqbal, K.; Grundke-Iqbal, I. 1999: Hyperphosphorylated tau in SY5Y cells: Similarities and dissimilarities to abnormally hyperphosphorylated tau from Alzheimer disease brain. FEBS Letters 453(1-2): 224-228
Wang, J.; Tung, Y.C.; Wang, Y.; Li, X.T.; Iqbal, K.; Grundke-Iqbal, I. 2001: Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Letters 507(1): 81-87
Andorfer, C.; Kress, Y.; Espinoza, M.; de Silva, R.; Tucker, K.L.; Barde, Y-Alain.; Duff, K.; Davies, P. 2003: Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Journal of Neurochemistry 86(3): 582-590
Foltz, D.R.; Nye, J.S. 2001: Hyperphosphorylation and association with RBP of the intracellular domain of Notch1. Biochemical and Biophysical Research Communications 286(3): 484-492
Kahle, P.J.; Neumann, M.; Ozmen, L.; Muller, V.; Jacobsen, H.; Spooren, W.; Fuss, B.; Mallon, B.; Macklin, W.B.; Fujiwara, H.; Hasegawa, M.; Iwatsubo, T.; Kretzschmar, H.A.; Haass, C. 2002: Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. Embo Reports 3(6): 583-588
Alonso, A.; Zaidi, T.; Novak, M.; Grundke-Iqbal, I.; Iqbal, K. 2001: Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proceedings of the National Academy of Sciences of the United States of America 98(12): 6923-6928
Uversky, V.N.; Winter, S.; Galzitskaya, O.V.; Kittler, L.; Lober, G. 1998: Hyperphosphorylation induces structural modification of tau-protein. FEBS Letters 439(1-2): 21-25
Garreau, Hé.; Hasan, R.Nilofer.; Renault, G.; Estruch, F.; Boy-Marcotte, E.; Jacquet, M. 2000: Hyperphosphorylation of Msn2p and Msn4p in response to heat shock and the diauxic shift is inhibited by cAMP in Saccharomyces cerevisiae. Microbiology 146: 2113-2120
Asghar, M.; Kansra, V.; Hussain, T.; Lokhandwala, M.F. 2001: Hyperphosphorylation of Na-pump contributes to defective renal dopamine response in old rats. Journal of the American Society of Nephrology: Jasn 12(2): 226-232
Treuner, K.; Okuyama, A.; Knippers, R.; Fackelmayer, F.O. 1999: Hyperphosphorylation of replication protein A middle subunit (RPA32) in apoptosis. Nucleic Acids Research 27(6): 1499-1504
Guise, S.; Braguer, D.; Carles, G.; Delacourte, A.; Briand, C. 2001: Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. Journal of Neuroscience Research 63(3): 257-267
Mcvicker, B.L.; Tuma, D.J.; Casey, C.A. 2000: Hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes following ethanol administration. Biochemical Pharmacology 60(3): 343-351
Neddermann, P.; Clementi, A.; De Francesco, R. 1999: Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. Journal of Virology 73(12): 9984-9991
Adam-Stitah, S.; Penna, L.; Chambon, P.; Rochette-Egly, C. 1999: Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. Journal of Biological Chemistry 274(27): 18932-18941
Banba, K.; Tanaka, N.; Fujioka, A.; Tajima, S. 1999: Hyperpigmentation caused by hyperthyroidism: Differences from the pigmentation of Addison's disease. Clinical and Experimental Dermatology 24(3): 196-198
Willems, M.; Munte, K.; Vrolijk, J.M.; Den Hollander, J.C.; Böhm, M.; Kemmeren, M.H.; De Man, R.A.; Brouwer, J.T. 2003: Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. British Journal of Dermatology 149(2): 390-394
Faraco, C.D.; Vaz, S.A.; Pástor, M.V.; Erickson, C.A. 2001: Hyperpigmentation in the Silkie fowl correlates with abnormal migration of fate-restricted melanoblasts and loss of environmental barrier molecules. Developmental Dynamics: An Official Publication of the American Association of Anatomists 220(3): 212-225
Monfrecola, G.; Procaccini, E.Maria.; D'Onofrio, D.; Roberti, G.; Liuzzi, R.; Staibano, S.; Manco, A.; De Rosa, G.; Santoianni, P. 2002: Hyperpigmentation induced by topical 5-aminolaevulinic acid plus visible light. Journal of Photochemistry and Photobiology. B Biology 68(2-3): 147-155
Martínez-Lázaro, R.; Cortés, A. 1999: Hyperplasia of all four parathyroid glands in renal failure visualized by Tc-99m tetrofosmin scintigraphy. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(7): 1795-1796
Zhdanov, V.S.; Sternby, N.H.; Drobkova, I.P.; Galakhov, I.E. 2000: Hyperplasia of coronary intima in young males in relation to development of coronary heart disease in adults. International Journal of Cardiology 76(1): 57-64
Hunt, J.P.; Chan, J.A.; Samoszuk, M.; Brynes, R.K.; Hernandez, A.M.; Bass, R.; Weisenburger, D.D.; Müller-Hermelink, K.; Nathwani, B.N. 2001: Hyperplasia of mantle/marginal zone B cells with clear cytoplasm in peripheral lymph nodes. a clinicopathologic study of 35 cases. American Journal of Clinical Pathology 116(4): 550-559
Landenberger, H.; Siepmann, K.; Rohrbach, J.-Martin 1999: Hyperplasia of sebaceous glands (Fordyce's disease) in an oral mucocutaneous graft: Follow-up over 45 years. Klinische Monatsblaetter fuer Augenheilkunde 214(3): 185-187
Takahashi, F.; Denda, M.; Finch, J.L.; Brown, A.J.; Slatopolsky, E. 2002: Hyperplasia of the parathyroid gland without secondary hyperparathyroidism. Kidney International 61(4): 1332-1338
Derwahl, M.; Studer, H. 2002: Hyperplasia versus adenoma in endocrine tissues: Are they different?. Trends in Endocrinology and Metabolism 13(1): 23-28
Sokolova, R.I.; Volkov, V.I.; Bulkina, O.S.; Zhdanov, V.S. 1999: Hyperplastic changes and aldosterone content in the adrenal cortex in essential hypertension and primary aldosteronism. Arkhiv Patologii 61(3): 11-14
Salazar, E.L.; Torres, J.A.; Avila, A.; Andrade, A. 2000: Hyperplastic changes and receptor status in the breast tissue of bodybuilders under anabolic-androgenic steroid stimulation. Archives of Andrology 45(1): 1-7
Costell, M.; Carmona, R.; Gustafsson, E.; González-Iriarte, M.; Fässler, R.; Muñoz-Chápuli, Rón. 2002: Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circulation Research 91(2): 158-164
Qunn, L.; Takemura, T.; Ikushima, S.; Ando, T.; Yanagawa, T.; Akiyama, O.; Oritsu, M.; Tanaka, N.; Kuroki, T. 2002: Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis. Virchows Archiv: An International Journal of Pathology 441(3): 271-278
Saccá, N. 2003: Hyperplastic gastric polyps and helicobacter pylori. Scandinavian Journal of Gastroenterology 38(8): 904
Abe, M.; MasumotoT; Ninomiya, T.; Iuchi, H.; Michitaka, K.; Horiike, N.; Kushihata, F.; Onji, M. 2000: Hyperplastic liver nodules associated with early-stage primary biliary cirrhosis mimicking hepatocellular carcinoma. Digestive Diseases and Sciences 45(8): 1563-1567
Isotalo, P.A.; Veinot, J.P.; Jabi, M. 2000: Hyperplastic mesothelial cells in mediastinal lymph node sinuses with extranodal lymphatic involvement. Archives of Pathology and Laboratory Medicine 124(4): 609-613
Meier, P.; Guetz, U.; Wiedemann, P. 1999: Hyperplastic persistent pupillary membrane and surgical treatment. Klinische Monatsblaetter fuer Augenheilkunde 214(4): 255-257
Leggett, B.A.; Devereaux, B.; Biden, K.; Searle, J.; Young, J.; Jass, J. 2001: Hyperplastic polyposis: association with colorectal cancer. American Journal of Surgical Pathology 25(2): 177-184
Jass, J.R.; Young, J.; Leggett, B.A. 2000: Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology 37(4): 295-301
Abraham, S.C.; Singh, V.K.; Yardley, J.H.; Wu, T.T. 2001: Hyperplastic polyps of the esophagus and esophagogastric junction: histologic and clinicopathologic findings. American Journal of Surgical Pathology 25(9): 1180-1187
Abraham, S.C.; Singh, V.K.; Yardley, J.H.; Wu, T.T. 2001: Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. American Journal of Surgical Pathology 25(4): 500-507
Inokuchi, S.; Kimura, K.; Sugaya, T.; Inokuchi, K.; Murakami, K.; Sakai, T. 2001: Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin Ii type 1a receptor null mutant mice. Kidney International 60(2): 722-731
Nitta, M.; Tsuiki, H.; Arima, Y.; Harada, K.; Nishizaki, T.; Sasaki, K.; Mimori, T.; Ushio, Y.; Saya, H. 2002: Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 7(2): 151-162
Nozaki, T.; Fujihara, H.; Kamada, N.; Ueda, O.; Takato, T.; Nakagama, H.; Sugimura, T.; Suzuki, H.; Masutani, M. 2001: Hyperploidy of embryonic fibroblasts derived from Parp-1 knockout mouse. Proceedings of the Japan Academy B Physical and Biological Sciences 77(6): 121-124
Lai, Y-Loong.; Chiou, W-Yi.; Lu, F-Jou. 2002: Hyperpnea-induced production of TBHP-initiated chemiluminescence in guinea pigs. Life Sciences 70(11): 1271-1277
White, R.; Hiley, C.R. 2000: Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K(+) channel openers. European Journal of Pharmacology 397(2-3): 279-290
Cadetti, L.; Belluzzi, O. 2001: Hyperpolarisation-activated current in glomerular cells of the rat olfactory bulb. Neuroreport 12(14): 3117-3120
Mccloskey, K.D.; Toland, H.M.; Hollywood, M.A.; Thornbury, K.D.; Mchale, N.G. 1999: Hyperpolarisation-activated inward current in isolated sheep mesenteric lymphatic smooth muscle. Journal of Physiology 521 Pt 1: 201-211
Eberle, B.; Markstaller, K.; Schreiber, W.G.; Kauczor, H.U. 2001: Hyperpolarised gases in magnetic resonance: a new tool for functional imaging of the lung. Swiss Medical Weekly 131(35-36): 503-509
Song, Y-M.; Ochi, R. 2002: Hyperpolarization and lysophosphatidylcholine induce inward currents and ethidium fluorescence in rabbit ventricular myocytes. Journal of Physiology 545(2): 463-473
Chen, S.J.; Wu, C.C.; Yang, S.N.; Lin, C.I.; Yen, M.H. 2000: Hyperpolarization contributes to vascular hyporeactivity in rats with lipopolysaccharide-induced endotoxic shock. Life Sciences 68(6): 659-668
Knöpfel, T.; Guatteo, E.; Bernardi, G.; Mercuri, N.B. 1998: Hyperpolarization induces a rise in intracellular sodium concentration in dopamine cells of the substantia nigra pars compacta. European Journal of Neuroscience 10(5): 1926-1929
Park, J.-Y.; Lee, D.; Maeng, J.-U.; Koh, D.-S.; Kim, K. 2002: Hyperpolarization, but not depolarization, increases intracellular Ca(2+) level in cultured chick myoblasts. Biochemical and Biophysical Research Communications 290(4): 1176-1182
Shaikh, A.G.; Finlayson, P.G. 2003: Hyperpolarization-activated (I(h)) conductances affect brainstem auditory neuron excitability. Hearing Research 183(1-2): 126-136
Chabbert, C.; Chambard, J.M.; Valmier, J.; Sans, A.; Desmadryl, G. 2001: Hyperpolarization-activated (Ih) current in mouse vestibular primary neurons. Neuroreport 12(12): 2701-2704
Richter, H.; Heinemann, U.; Eder, C. 2000: Hyperpolarization-activated cation currents in stellate and pyramidal neurons of rat entorhinal cortex. Neuroscience Letters 281(1): 33-36
Berger, T.; Senn, W.; Lüscher, H.-R. 2003: Hyperpolarization-activated current Ih disconnects somatic and dendritic spike initiation zones in layer V pyramidal neurons. Journal of Neurophysiology 90(4): 2428-2437
Iwahori, Y.; Ikegaya, Y.; Matsuki, N. 2002: Hyperpolarization-activated current I(h) in nucleus of solitary tract neurons: regional difference in serotonergic modulation. Japanese Journal of Pharmacology 88(4): 459-462
Mironov, S.L.; Langohr, K.; Richter, D.W. 2000: Hyperpolarization-activated current, Ih, in inspiratory brainstem neurons and its inhibition by hypoxia. European Journal of Neuroscience 12(2): 520-526
Southan, A.P.; Morris, N.P.; Stephens, G.J.; Robertson, B. 2000: Hyperpolarization-activated currents in presynaptic terminals of mouse cerebellar basket cells. Journal of Physiology 526 Pt 1: 91-97
Moroni, A.; Gorza, L.; Beltrame, M.; Gravante, B.; Vaccari, T.; Bianchi, M.E.; Altomare, C.; Longhi, R.; Heurteaux, C.; Vitadello, M.; Malgaroli, A.; DiFrancesco, D. 2001: Hyperpolarization-activated cyclic nucleotide-gated channel 1 is a molecular determinant of the cardiac pacemaker current I(f). Journal of Biological Chemistry 276(31): 29233-29241
Yasui, K.; Liu, W.; Kodama, I. 1999: Hyperpolarization-activated inward current (If) in an early-stage embryonic mouse cardiac cell. Environmental Medicine 43(1): 31-32
Raymond, V.; Lapied, B. 1999: Hyperpolarization-activated inward potassium and calcium-sensitive chloride currents in beating pacemaker insect neurosecretory cells (dorsal unpaired median neurons). Neuroscience 93(3): 1207-1218
Cho, W.J.; Drescher, M.J.; Hatfield, J.S.; Bessert, D.A.; Skoff, R.P.; Drescher, D.G. 2003: Hyperpolarization-activated, cyclic AMP-gated, HCN1-like cation channel: The primary, full-length HCN isoform expressed in a saccular hair-cell layer. Neuroscience 118(2): 525-534
Bal, R.; Oertel, D. 2000: Hyperpolarization-activated, mixed-cation current (I(h)) in octopus cells of the mammalian cochlear nucleus. Journal of Neurophysiology 84(2): 806-817
Wolber, J.; Cherubini, A.; Leach, M.O.; Bifone, A. 2000: Hyperpolarized 129Xe NMR as a probe for blood oxygenation. Magnetic Resonance in Medicine 43(4): 491-496
Svensson, J.; Månsson, S.; Johansson, E.; Petersson, J.S.; Olsson, L.E. 2003: Hyperpolarized 13C MR angiography using trueFISP. Magnetic Resonance in Medicine 50(2): 256-262
Chen, X.J.; Chawla, M.S.; Cofer, G.P.; Hedlund, L.W.; Möller, H.E.; Johnson, G.A. 1998: Hyperpolarized 3He NMR lineshape measurements in the live guinea pig lung. Magnetic Resonance in Medicine 40(1): 61-65
Chawla, M.S.; Chen, X.J.; Cofer, G.P.; Hedlund, L.W.; Kerby, M.B.; Ottoboni, T.B.; Johnson, G.A. 2000: Hyperpolarized 3He microspheres as a novel vascular signal source for MRI. Magnetic Resonance in Medicine 43(3): 440-445
Mayo, J.R.; Hayden, M.E. 2002: Hyperpolarized helium 3 diffusion imaging of the lung. Radiology 222(1): 8-11
Bains, J.S.; Ferguson, A.V. 1998: Hyperpolarizing after-potentials regulate generation of long-duration plateau depolarizations in rat paraventricular nucleus neurons. European Journal of Neuroscience 10(4): 1412-1421
Titz, S.; Hans, M.; Kelsch, W.; Lewen, A.; Swandulla, D.; Misgeld, U. 2003: Hyperpolarizing inhibition develops without trophic support by GABA in cultured rat midbrain neurons. Journal of Physiology 550(Part 3): 719-730
Kotani, S.; Hasegawa, J.; Meng, H.; Suzuki, T.; Sato, K.; Sakakibara, M.; Takiguchi, M.; Tokimasa, T. 2001: Hyperpolarizing shift by quinine in the steady-state inactivation curve of delayed rectifier-type potassium current in bullfrog sympathetic neurons. Neuroscience Letters 300(2): 87-90
Cheung, A.L.; Chien, Y.T.; Bayer, A.S. 1999: Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infection and Immunity 67(3): 1331-1337
Xi, J.; Wu, Q.; Yan, Y.; Zhang, Z.; Yu, P.H.; Cheung, M.K.; Zhang, R.; Chen, G.Q. 2000: Hyperproduction of polyesters consisting of medium-chain-length hydroxyalkanoate monomers by strain Pseudomonas stutzeri 1317. Antonie van Leeuwenhoek 78(1): 43-49
Gama, R.; Medina-Layachi, N.; Ranganath, L.; Hampton, S.; Morgan, L.; Marks, V. 2000: Hyperproinsulinaemia in elderly subjects: evidence for age-related pancreatic beta-cell dysfunction. Annals of Clinical Biochemistry 37: 367-371
Ruige, J.B.; Dekker, J.M.; Nijpels, G.; Popp-Snijders, C.; Stehouwer, C.D.; Kostense, P.J.; Bouter, L.M.; Heine, R.J. 1999: Hyperproinsulinaemia in impaired glucose tolerance is associated with a delayed insulin response to glucose. Diabetologia 42(2): 177-180
Grill, V.; Dinesen, B.; Carlsson, S.; Efendic, S.; Pedersen, O.; Ostenson, C-G. 2002: Hyperproinsulinemia and proinsulin-to-insulin ratios in Swedish middle-aged men: association with glycemia and insulin resistance but not with family history of diabetes. American Journal of Epidemiology 155(9): 834-841
Vauhkonen, I.K.; Niskanen, L.K.; Mykkänen, L.; Haffner, S.M.; Uusitupa, M.I.; Laakso, M. 2000: Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes. European Journal of Endocrinology 143(2): 251-260
Wieck, A.; Haddad, P. 2002: Hyperprolactinaemia caused by antipsychotic drugs. Bmj 324(7332): 250-252
Pitsiladis, Y.P.; Strachan, A.T.; Davidson, I.; Maughan, R.J. 2002: Hyperprolactinaemia during prolonged exercise in the heat: evidence for a centrally mediated component of fatigue in trained cyclists. Experimental Physiology 87(2): 215-226
Limas, C.J.; Kroupis, C.; Haidaroglou, A.; Cokkinos, D.V. 2002: Hyperprolactinaemia in patients with heart failure: Clinical and immunogenetic correlations. European Journal of Clinical Investigation 32(2): 74-78
Naidoo, U.; Goff, D.C.; Klibanski, A. 2003: Hyperprolactinemia and bone mineral density: The potential impact of antipsychotic agents. Psychoneuroendocrinology 28(Suppl): 97-108
Santala, M.; Suvanto-Luukkonen, E.; Kyllönen, A.; Ruokonen, A.; Puistola, U. 2001: Hyperprolactinemia complicating juvenile granulosa cell tumor of the ovary. Gynecologic Oncology 82(2): 389-391
Imrich, R.; Rovensky, J.; Cervenakova, Z.; Ksinantova, L.; Kvetnansky, R.; Koska, J. 2002: Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women. International Journal of Tissue Reactions 24(2): 73-78
Cavaco, B.; Prazeres, S.; Santos, M.A.; Sobrinho, L.G.; Leite, V. 1999: Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays. Journal of Endocrinological Investigation 22(3): 203-208
Mok, C.C.; Lau, C.S.; Lee, K.W.; Wong, R.W. 1998: Hyperprolactinemia in males with systemic lupus erythematosus. Journal of Rheumatology 25(12): 2357-2363
De Rosa, M.; Zarrilli, S.; Di Sarno, A.; Milano, N.; Gaccione, M.; Boggia, B.; Lombardi, G.; Colao, A. 2003: Hyperprolactinemia in men: clinical and biochemical features and response to treatment. Endocrine 20(1-2): 75-82
Yamasaki, K.; Horiuchi, I.; Minohara, M.; Osoegawa, M.; Kawano, Y.; Ohyagi, Y.; Yamada, T.; Kira, J. 2000: Hyperprolactinemia in optico-spinal multiple sclerosis. Internal Medicine 39(4): 296-299
Wallaschofski, H.; Eigenthaler, M.; Kiefer, M.; Donné, M.; Hentschel, B.; Gertz, H.J.; Lohmann, T. 2003: Hyperprolactinemia in patients on antipsychotic drugs causes ADP-stimulated platelet activation that might explain the increased risk for venous thromboembolism: pilot study. Journal of Clinical Psychopharmacology 23(5): 479-483
Kinon, B.J.; Gilmore, J.A.; Liu, H.; Halbreich, U.M. 2003: Hyperprolactinemia in response to antipsychotic drugs: Characterization across comparative clinical trials. Psychoneuroendocrinology 28(Suppl): 69-82
Subramanian, S.; Shanthi, S.; Kumari, T.M.K.; Govindarajulu, P.; Aruldhas, M.M. 2000: Hyperprolactinemia is associated with a region specific stimulation of cardiovascular tissue adenosine triphosphatases activity in female wistar rats. Journal of Animal Morphology and Physiology 47(1-2): 45-50
Vasioukhin, V.; Bauer, C.; Degenstein, L.; Wise, B.; Fuchs, E. 2001: Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104(4): 605-617
Bai, F.; Xi, J.Hua.; Wawrousek, E.F.; Fleming, T.P.; Andley, U.P. 2003: Hyperproliferation and p53 status of lens epithelial cells derived from alphaB-crystallin knockout mice. Journal of Biological Chemistry 278(38): 36876-36886
Szabó, A.Kenderessy.; Bos, J.D.; Das, P.K. 2002: Hyperproliferation of normally quiescent keratinocytes in non-lesional psoriatic skin due to high calcium concentration (an organotypic culture model). Acta Microbiologica et Immunologica Hungarica 49(1): 129-140
Reichelt, J.; Magin, T.M. 2002: Hyperproliferation, induction of c-Myc and 14-3-3sigma, but no cell fragility in keratin-10-null mice. Journal of Cell Science 115(Pt 13): 2639-2650
Dombrowski, F.; Klotz, L.; Hacker, H.J.; Li, Y.; Klingmüller, D.; Brix, K.; Herzog, V.; Bannasch, P. 2000: Hyperproliferative hepatocellular alterations after intraportal transplantation of thyroid follicles. American Journal of Pathology 156(1): 99-113
Arpin, C.; Angelov, G.; Walzer, T.; Tomkowiak, M.; Beloeil, L.; Marvel, J. 2002: Hyperproliferative response of a monoclonal memory CD8 T cell population is characterized by an increased frequency of clonogenic precursors. Journal of Immunology 168(5): 2147-2153
Angell, C.Austen.; Wang, L.Min. 2003: Hyperquenching and cold equilibration strategies for the study of liquid--liquid and protein folding transitions. Biophysical Chemistry 105(2-3): 621-637
al-Ramahi, M.; Leader, A. 1999: Hyperreactio luteinalis associated with chronic renal failure. Human Reproduction 14(2): 416-418
Takeda, T.; Minekawa, R.; Makino, M.; Sugiyama, T.; Murata, Y.; Suehara, N. 2002: Hyperreactio luteinalis associated with severe twin-to-twin transfusion syndrome. Gynecologic and Obstetric Investigation 53(4): 243-246
Check, J.H.; Choe, J.K.; Nazari, A. 2000: Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed serum follicle stimulating concentrations in a triplet pregnancy. Human Reproduction 15(5): 1043-1045
Csapó, Z.; Szabó, I.; Tóth, M.; Dévényi, N.; Papp, Z. 1999: Hyperreactio luteinalis in a normal singleton pregnancy. A case report. Journal of Reproductive Medicine 44(1): 53-56
Coccia, M.Elisabetta.; Pasquini, L.; Comparetto, C.; Scarselli, G. 2003: Hyperreactio luteinalis in a woman with high-risk factors. A case report. Journal of Reproductive Medicine 48(2): 127-129
Hamamoto, Y.; Nagai, K.; Yasui, H.; Muto, M. 2000: Hyperreactivity of pseudoxanthoma elasticum-affected dermis to vitamin D3. Journal of the American Academy of Dermatology 42(4): 685-687
Irsalieva, F.K.; Nizamov, K.F. 2001: Hyperreactivity of the bronchi as an efficiency factor of budesonid inhalation in patients with bronchial asthma. Uzbekiston Tibbiet Zhurnali (2-3): 104-106
Kuwabara, S.; Ogawara, K.; Koga, M.; Mori, M.; Hattori, T.; Yuki, N. 1999: Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. Journal of Neurology Neurosurgery and Psychiatry 67(2): 180-184
Kuwabara, S.; Nakata, M.; Sung, J-Ying.; Mori, M.; Kato, N.; Hattori, T.; Koga, M.; Yuki, N. 2002: Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. Journal of the Neurological Sciences 199(1-2): 89-92
Shaker, H.S.; Tu, L.M.; Kalfopoulos, M.; Hassouna, M.; Dion, S.; Elhilali, M. 1998: Hyperreflexia of the urinary bladder: Possible role of the efferent function of the capsaicin sensitive primary afferents. Journal of Urology 160(6 Pt 1): 2232-2239
Hurst, R.; Korytowski, W.; Kriska, T.; Esworthy, R.S.; Chu, F.F.; Girotti, A.W. 2001: Hyperresistance to cholesterol hydroperoxide-induced peroxidative injury and apoptotic death in a tumor cell line that overexpresses glutathione peroxidase isotype-4. Free Radical Biology and Medicine 31(9): 1051-1065
Kriska, T.; Korytowski, W.; Girotti, A.W. 2002: Hyperresistance to photosensitized lipid peroxidation and apoptotic killing in 5-aminolevulinate-treated tumor cells overexpressing mitochondrial GPX4. Free Radical Biology and Medicine 33(10): 1389-1402
DeLorme, M.P.; Yang, H.; Elbon-Copp, C.; Gao, X.; Barraclough-Mitchell, H.; Bassett, D.J.P. 2002: Hyperresponsive airways correlate with lung tissue inflammatory cell changes in ozone-exposed rats. Journal of Toxicology and Environmental Health. Part a 65(19): 1453-1470
Turner, P.J.; Foreman, J.C. 1999: Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease. Mediators of Inflammation 8(3): 133-146
Rinne, T.; de Kloet, E.Ronald.; Wouters, L.; Goekoop, J.G.; DeRijk, R.H.; van den Brink, W. 2002: Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biological Psychiatry 52(11): 1102-1112
Daenen, E.W.P.M.; Wolterink, G.; Van Ree, J.M. 2003: Hyperresponsiveness to phencyclidine in animals lesioned in the amygdala on day 7 of life. Implications for an animal model of schizophrenia. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 13(4): 273-279
de Jonge, Tás.; Dubousset, J.F.; Illés, Tás. 2002: Hyperrotatory paradoxic kyphosis. Spine 27(4): 393-398
Gordon, C. 2000: Hypersaline lagoons as conservation habitats: Macro-invertebrates at Muni Lagoon, Ghana. Biodiversity and Conservation 9(4): 465-478
Gunde-Cimermana; Zalarb; de Hoogc S; Plemenitasd 2000: Hypersaline waters in salterns - natural ecological niches for halophilic black yeasts. FEMS Microbiology Ecology 32(3): 235-240
Liu, H.; Buskey, E., J. 2000: Hypersalinity enhances the production of extracellular polymeric substance (EPS) in the Texas brown tide alga, Aureoumbra lagunensis (Pelagophyceae). Journal of Phycology 36(1): 71-77
Montague, P.Read.; Berns, G.S.; Cohen, J.D.; McClure, S.M.; Pagnoni, G.; Dhamala, M.; Wiest, M.C.; Karpov, I.; King, R.D.; Apple, N.; Fisher, R.E. 2002: Hyperscanning: Simultaneous fMRI during linked social interactions. NeuroImage 16(4): 1159-1164
Ibáñez, L.; Valls, C.; Cols, M.; Ferrer, A.; Marcos, M.V.; De Zegher, F. 2002: Hypersecretion of FSH in infant boys and girls born small for gestational age. Journal of Clinical Endocrinology and Metabolism 87(5): 1986-1988
Lindgren, R.; Gunnarsson, C.; Jakobsson, A.; Hammar, M. 2000: Hypersecretion of ovarian androgens may be gonadotrophin dependent many years after menopause. Maturitas 34(1): 43-46
Capurso, G.; Martino, G.; Grossi, C.; Annibale, B.; Delle Fave, G. 2000: Hypersecretory duodenal ulcer and Helicobacter pylori infection: a four-year follow-up study. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 32(2): 119-124
Wakatsuki, S.; Hirokawa, M.; Horiguchi, H.; Kanahara, T.; Manabe, T.; Sano, T. 2000: Hypersegmentation of inflammatory cells in Langerhans cell granulomatosis. Diagnostic Cytopathology 23(4): 238-241
Touyz, L.Z.; Stern, J. 1999: Hypersensitive dentinal pain attenuation with potassium nitrate. General Dentistry 47(1): 42-45
Bungert, J.; Tanimoto, K.; Patel, S.; Liu, Q.; Fear, M.; Engel, J.D. 1999: Hypersensitive site 2 specifies a unique function within the human beta-globin locus control region to stimulate globin gene transcription. Molecular and Cellular Biology 19(4): 3062-3072
Kelemen, B.R.; Klink, T.A.; Behlke, M.A.; Eubanks, S.R.; Leland, P.A.; Raines, R.T. 1999: Hypersensitive substrate for ribonucleases. Nucleic Acids Research 27(18): 3696-3701
Hammer, B.; Link, A.; Wagner, A.; Boehm, M. 2001: Hypersensitivitaetssyndrom unter Therapie mit Allopurinol bei asymptomatischer Hyperurikaemie mit toedlichem Ausgang. DMW Deutsche Medizinische Wochenschrift 126(47): 1331-1334
Rieder, M.J. 2001: Hypersensitivity adverse drug reactions in children: Pathophysiology and therapeutic implications. Current Therapeutic Research 62(12): 913-929
Azpiroz, F. 2002: Hypersensitivity in functional gastrointestinal disorders. Gut 51(Suppl): I25-I28
Zaacks, S.M.; Klein, L.; Tan, C.D.; Rodriguez, E.R.; Leikin, J.B. 1999: Hypersensitivity myocarditis associated with ephedra use. Journal of Toxicology. Clinical Toxicology 37(4): 485-489
Kurt, T.L. 2000: Hypersensitivity myocarditis with ephedra use. Journal of Toxicology. Clinical Toxicology 38(3): 351
Horton, J.K.; Joyce-Gray, D.F.; Pachkowski, B.F.; Swenberg, J.A.; Wilson, S.H. 2003: Hypersensitivity of DNA polymerase beta null mouse fibroblasts reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA lesions. Dna Repair 2(1): 27-48
Kozmin, S.G.; Pavlov, Y.I.; Dunn, R.L.; Schaaper, R.M. 2000: Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis. Journal of Bacteriology 182(12): 3361-3367
Tsai, J.J.; Kao, M.H.; Wu, C.H. 1998: Hypersensitivity of bronchial asthmatics to cockroach in Taiwan. comparative study between American and German cockroaches. International Archives of Allergy and Immunology 117(3): 180-186
Lee, L.-Y.; Kwong, K.; Lin, Y.S.; Gu, Q. 2002: Hypersensitivity of bronchopulmonary C-fibers induced by airway mucosal inflammation: cellular mechanisms. Pulmonary Pharmacology and Therapeutics 15(3): 199-204
Axelrad, A.A.; Eskinazi, D.; Correa, P.N.; Amato, D. 2000: Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia. Blood 96(10): 3310-3321
Peeters, M.; Page, Gène.; Maloteaux, J-Marie.; Hermans, E. 2002: Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine. Brain Research 949(1-2): 32-41
Levallois, P. 2002: Hypersensitivity of human subjects to environmental electric and magnetic field exposure: a review of the literature. Environmental Health Perspectives 110(Suppl): 613-618
Mutoh, T.; Tsubone, H. 2003: Hypersensitivity of laryngeal C-fibers induced by volatile anesthetics in young guinea pigs. American Journal of Respiratory and Critical Care Medicine 167(4): 557-562
López, J.R.; Contreras, J.; Linares, N.; Allen, P.D. 2000: Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+. Anesthesiology 92(6): 1799-1806
Aoki, H.; Ozeki, Y.; Yamada, N. 2001: Hypersensitivity of melatonin suppression in response to light in patients with delayed sleep phase syndrome. Chronobiology International 18(2): 263-271
Adachi, N.; Suzuki, H.; Iiizumi, S.; Koyama, H. 2003: Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. Journal of Biological Chemistry 278(38): 35897-35902
Gu, Q.; Lee, L.Y. 2001: Hypersensitivity of pulmonary C fibre afferents induced by cationic proteins in the rat. Journal of Physiology 537(Pt 3): 887-897
Chen, S-Rui.; Pan, H-Lin. 2002: Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. Journal of Neurophysiology 87(6): 2726-2733
Axéll, T. 2001: Hypersensitivity of the oral mucosa: Clinics and pathology. Acta Odontologica Scandinavica 59(5): 315-319
Woo, M.H.; Hak, L.J.; Storm, M.C.; Sandlund, J.T.; Ribeiro, R.C.; Rivera, G.K.; Rubnitz, J.E.; Harrison, P.L.; Wang, B.; Evans, W.E.; Pui, C.H.; Relling, M.V. 2000: Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(7): 1525-1532
Timmer, S.J.; Amundson, D.E.; Malone, J.D. 2002: Hypersensitivity pneumonitis following anthrax vaccination. Chest 122(2): 741-745
Hodgson, M.J.; Bracker, A.; Yang, C.; Storey, E.; Jarvis, B.J.; Milton, D.; Lummus, Z.; Bernstein, D.; Cole, S. 2001: Hypersensitivity pneumonitis in a metal-working environment. American Journal of Industrial Medicine 39(6): 616-628
Tsushima, K.; Fujimoto, K.; Yamazaki, Y.; Takamizawa, A.; Amari, T.; Koizumi, T.; Kubo, K. 2001: Hypersensitivity pneumonitis induced by spores of Lyophyllum aggregatum. Chest 120(4): 1085-1093
Wild, L.G. 2000: Hypersensitivity pneumonitis: A childhood disease?. Pediatric Asthma Allergy and Immunology 14(1): 15-31
Patel, A.M.; Ryu, J.H.; Reed, C.E. 2001: Hypersensitivity pneumonitis: current concepts and future questions. Journal of Allergy and Clinical Immunology 108(5): 661-670
Merrill, W. 2001: Hypersensitivity pneumonitis: just think of it!. Chest 120(4): 1055-1057
Shukunami, K.; Kurokawa, T.; Kubo, M.; Kaneshima, M.; Kamitani, N.; Kotsuji, F. 1999: Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin. Tumori 85(4): 297-298
Menczer, J.; Barda, G.; Glezerman, M.; Hyat, H.; Brenner, Y.; Brickman, C.M.; Tanai, A. 1999: Hypersensitivity reaction to carboplatin. Results of skin tests. European Journal of Gynaecological Oncology 20(3): 214-216
Porzio, G.; Marchetti, P.; Paris, I.; Narducci, F.; Ricevuto, E.; Ficorella, C. 2002: Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin. European Journal of Gynaecological Oncology 23(4): 335-336
Koren, C.; Yerushalmi, R.; Katz, A.; Malik, H.; Sulkes, A.; Fenig, E. 2002: Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy. American Journal of Clinical Oncology 25(6): 625-626
Jarnicki, A.G.; Tsuji, T.; Thomas, W.R. 2002: Hypersensitivity reactions after respiratory sensitization: Effect of intranasal peptides containing T-cell epitopes. Journal of Allergy and Clinical Immunology 110(4): 610-616
Robinson, J.B.; Singh, D.; Bodurka-Bevers, D.C.; Wharton, J.T.; Gershenson, D.M.; Wolf, J.K. 2001: Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecologic Oncology 82(3): 550-558
McMahon, A.D.; Evans, J.M.; MacDonald, T.M. 2001: Hypersensitivity reactions associated with exposure to naproxen and ibuprofen: A cohort study. Journal of Clinical Epidemiology 54(12): 1271-1274
Pechlaner, C.; Knapp, E.; Wiedermann, C.J. 2001: Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 12(6): 491-494
Hetherington, S.; Mcguirk, S.; Powell, G.; Cutrell, A.; Naderer, O.; Spreen, B.; Lafon, S.; Pearce, G.; Steel, H. 2001: Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clinical Therapeutics 23(10): 1603-1614
Chanda, M.; Mackenzie, P.; Day, J.H. 2000: Hypersensitivity reactions following laminaria placement. Contraception 62(2): 105-106
van Houwelingen, A.H.; de Jager, S.C.A.; Kool, M.; van Heuven-Nolsen, D.; Kraneveld, A.D.; Nijkamp, F.P. 2002: Hypersensitivity reactions in mouse airways after a single and a repeated hapten challenge. Inflammation Research: Official Journal of the European Histamine Research Society . 51(2): 63-68
Cormio, G.; Di Vagno, G.; Melilli, G.A.; Cazzolla, A.; Di Gesù, G.; Carriero, C.; Cramarossa, D.; Loverro, G.; Selvaggi, L. 1999: Hypersensitivity reactions in ovarian cancer patients receiving paclitaxel. Journal of ChemoTherapy 11(5): 407-409
Naisbitt, D.J.; Britschgi, M.; Wong, G.; Farrell, J.; Depta, J.P.H.; Chadwick, D.W.; Pichler, W.J.; Pirmohamed, M.; Park, B.K. 2003: Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Molecular Pharmacology 63(3): 732-741
Polyzos, A.; Tsavaris, N.; Kosmas, C.; Arnaouti, T.; Kalahanis, N.; Tsigris, C.; Giannopoulos, A.; Karatzas, G.; Giannikos, L.; Sfikakis, P.P. 2001: Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience. Oncology 61(2): 129-133
Shukunami, K.; Kurokawa, T.; Kawakami, Y.; Kubo, M.; Kotsuji, F. 1999: Hypersensitivity reactions to intraperitoneal administration of carboplatin in ovarian cancer: The first report of a case. Gynecologic Oncology 72(3): 431-432
Hietanen, M.; Hämäläinen, A-Maija.; Husman, T. 2002: Hypersensitivity symptoms associated with exposure to cellular telephones: No causal link. Bioelectromagnetics 23(4): 264-270
Milionis, H.J.; Skopelitou, A.; Elisaf, M.S. 2000: Hypersensitivity syndrome caused by amitriptyline administration. Postgraduate Medical Journal 76(896): 361-363
Conilleau, V.; Dompmartin, A.; Verneuil, L.; Michel, M.; Leroy, D. 1999: Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis 41(3): 141-144
Hamer, H.M.; Morris, H.H. 1999: Hypersensitivity syndrome to antiepileptic drugs: a review including new anticonvulsants. Cleveland Clinic Journal of Medicine 66(4): 239-245
Gomot, M.; Giard, M-Hélène.; Adrien, J-Louis.; Barthelemy, C.; Bruneau, N. 2002: Hypersensitivity to acoustic change in children with autism: Electrophysiological evidence of left frontal cortex dysfunctioning. Psychophysiology 39(5): 577-584
Pichierri, P.; Franchitto, A.; Piergentili, R.; Colussi, C.; Palitti, F. 2001: Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair. Carcinogenesis 22(11): 1781-1787
Schiavetti, A.; Varrasso, G.; Maurizi, P.; Castello, M.A. 1999: Hypersensitivity to carboplatin in children. Medical and Pediatric Oncology 32(3): 183-185
Hallab, N.; Jacobs, J.J.; Black, J. 2000: Hypersensitivity to metallic biomaterials: A review of leukocyte migration inhibition assays. Biomaterials 21(13): 1301-1314
Chung, J.Seop.; Shin, H.Jin.; Lee, E.Yup.; Cho, G.Jae. 2003: Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in Korea. Korean Journal of Internal Medicine 18(1): 50-52
Hidestål, J.; Fredriksen, S.; Hallén, M.; Westerdahl, J.; Thysell, H.; Bodelsson, M. 2002: Hypersensitivity to noradrenaline in human omental vein but not artery isolated from a patient with idiopathic orthostatic hypotension. Autonomic Neuroscience: Basic and Clinical 97(1): 55-58
Sato, K.; Kazama, J.James.; Wada, Y.; Maruyama, H.; Narita, I.; Gejyo, F.; Sugiyama, K.; Satoh, H. 2002: Hypersensitivity to paraoxybenzoic Acid esters (parabens) in a dialysis patient. Nephron 92(3): 728-729
Levy, M. 2000: Hypersensitivity to pyrazolones. Thorax 55 Suppl. 2: S72-S74
Narayan, A.; Tuck-Muller, C.; Weissbecker, K.; Smeets, D.; Ehrlich, M. 2000: Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. Mutation Research 456(1-2): 1-15
Andersson, G.; Lindvall, N.; Hursti, T.; Carlbring, P. 2002: Hypersensitivity to sound (hyperacusis): a prevalence study conducted via the Internet and post. International Journal of Audiology 41(8): 545-554
Verne, G.N.; Robinson, M.E.; Price, D.D. 2001: Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 93(1): 7-14
Nalbant, S.; Koc, B.; Top, C.; Kucukardali, Y.; Baykal, Y.; Danaci, M.; Kocer, I.H. 2002: Hypersensitivity vasculitis and cytokines. Rheumatology International 22(6): 244-248
Hanelt, S.; Karner, J.; Peichl, P.; Hackl, W.; Klimpfinger, M. 1999: Hypersensitivity vasculitis causing an acute abdomen. Wiener Klinische Wochenschrift 111(6): 226-229
Stein, D.J.; Black, D.W.; Shapira, N.A.; Spitzer, R.L. 2001: Hypersexual disorder and preoccupation with internet pornography. American Journal of Psychiatry 158(10): 1590-1594
Vázquez-Moreno, L.; Candia-Plata, M.C.; Robles-Burgueño, M.R. 2001: Hypersialylated macromolecular serum immunoglobulin A1 in type 2 diabetes mellitus. Clinical Biochemistry 34(1): 35-41
Elliott, M.A.; Jorgensen, H.G.; Smith, K.D. 1998: Hypersialylation of alpha1-acid glycoprotein in rheumatoid arthritis. Pharmacy and Pharmacology Communications 4(11): 545-547
Guilleminault, C.; Yuen, K.M.; Gulevich, M.G.; Karadeniz, D.; Leger, D.; Philip, P. 2000: Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology 54(3): 653-659
Kato, T.; Kanbayashi, T.; Yamamoto, K.; Nakano, T.; Shimizu, T.; Hashimoto, T.; Ikeda, S-ichi. 2003: Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Internal Medicine 42(8): 743-745
Eisensehr, I.; Noachtar, S.; von Schlippenbach, C.; Uttner, I.; Kleine, J.; Seelos, K.; Helmchen, C. 2003: Hypersomnia associated with bilateral posterior hypothalamic lesion. A polysomnographic case study. European Neurology 49(3): 169-172
Smith, R.P.; Pépin, J.L.; Catterall, J.R.; Lévy, P.A. 1999: Hypersomnia following uvulopalatopharyngoplasty for snoring. European Respiratory Journal 14(1): 239-241
Firneisz, G.; Szalay, F.; Halasz, P.; Komoly, S. 2000: Hypersomnia in Wilson's disease: An unusual symptom in an unusual case. Acta Neurologica Scandinavica 101(4): 286-288
Manni, R.; Politini, L.; Nobili, L.; Ferrillo, F.; Livieri, C.; Veneselli, E.; Biancheri, R.; Martinetti, M.; Tartara, A. 2001: Hypersomnia in the Prader Willi syndrome: Clinical-electrophysiological features and underlying factors. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 112(5): 800-805
Alberotanza, L.; Brando, V.E.; Ravagnan, G.; Zandonella, A. 1999: Hyperspectral aerial images. A valuable tool for submerged vegetation recognition in the Orbetello Lagoons, Italy. International Journal of Remote Sensing 20(3): 523-533
Holden, H.; Ledrew, E. 2001: Hyperspectral discrimination of healthy versus stressed corals using in situ reflectance. Journal of Coastal ResearchFall; 17(4): 850-858
Holden, H.; Ledrew, E. 1999: Hyperspectral identification of coral reef features. International Journal of Remote Sensing 20(13): 2545-2563
Schultz, R.A.; Nielsen, T.; Zavaleta, J.R.; Ruch, R.; Wyatt, R.; Garner, H.R. 2001: Hyperspectral imaging: A novel approach for microscopic analysis. Cytometry 43(4): 239-247
Akimaru, K.; Onda, M.; Tajiri, T.; Yoshida, H.; Yokomuro, S.; Mamada, Y.; Taniai, N. 2001: Hypersplenism induced by hepatectomy. Hepato-Gastroenterology 48(40): 1170-1175
Musolino, C.; Calabrò, L.; Alonci, A.; Quartarone, C.; Bellomo, G.; Neri, S.; Rizzo, V.; Pernice, F.; Frisina, N. 1999: Hypersplenism: current status and perspectives. Recenti Progressi in Medicina 90(9): 488-494
Wüstefeld, T.; Rakemann, T.; Kubicka, S.; Manns, M.P.; Trautwein, C. 2000: Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 32(3): 514-522
Anderson, J.A.; Fredenburgh, J.C.; Stafford, A.R.; Guo, Y.S.; Hirsh, J.; Ghazarossian, V.; Weitz, J.I. 2001: Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase. Journal of Biological Chemistry 276(13): 9755-9761
Jagannath, C.; Hoffmann, H.; Sepulveda, E.; Actor, J.K.; Wetsel, R.A.; Hunter, R.L. 2000: Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scandinavian Journal of Immunology 52(4): 369-379
Coleman, F.T.; Mueschenborn, S.; Meluleni, G.; Ray, C.; Carey, V.J.; Vargas, S.O.; Cannon, C.L.; Ausubel, F.M.; Pier, G.B. 2003: Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. Proceedings of the National Academy of Sciences of the United States of America 100(4): 1949-1954
Masuda, N.; Sakagawa, E.; Ohya, S.; Gotoh, N.; Nishino, T. 2001: Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase. Antimicrobial Agents and ChemoTherapy 45(4): 1284-1286
Moreno, S.; Casado, J.é L.; Pérez-Elías, M.ía.J.; Dronda, F.; Antela, A.; Moreno, A.; Gutiérrez, C. 2003: Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1. Aids 17(9): 1413-1414
Whitcomb, J.M.; Huang, W.; Limoli, K.; Paxinos, E.; Wrin, T.; Skowron, G.; Deeks, S.G.; Bates, M.; Hellmann, N.S.; Petropoulos, C.J. 2002: Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates. Aids 16(15): F41-F47
Dustan, H.P. 2000: Hypertension. Journal of the American College of Cardiology 35(5 Supp. B): 10B-12B
Anonymous 2001: Hypertension clinical guideline 2000. South African Medical Journal 91(2 Pt 2): 163-172
Midtvedt, K.; Hartmann, A. 2002: Hypertension after kidney transplantation: are treatment guidelines emerging?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 17(7): 1166-1169
Zhang, R.; Leslie, B.; Boudreaux, J.Philip.; Frey, D.; Reisin, E. 2003: Hypertension after kidney transplantation: impact, pathogenesis and therapy. American Journal of the Medical Sciences 325(4): 202-208
Taler, S.J.; Textor, S.C.; Canzanello, V.J.; Schwartz, L.; Porayko, M.K.; Wiesner, R.H.; Krom, R.A. 2000: Hypertension after liver transplantation: A predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations. American Journal of Hypertension 13(3): 231-239
Woods, L.L.; Weeks, D.A.; Rasch, R. 2001: Hypertension after neonatal uninephrectomy in rats precedes glomerular damage. Hypertension 38(3): 337-342
Hricik, D.E.; Chareandee, C.; Knauss, T.C.; Schulak, J.A. 2000: Hypertension after pancreas-kidney transplantation: role of bladder versus enteric pancreatic drainage. Transplantation 70(3): 494-496
Briones, A.M.; Alonso, Mía.J.; Hernanz, R.; Tovar, S.; Vila, E.; Salaices, M. 2002: Hypertension alters the participation of contractile prostanoids and superoxide anions in lipopolysaccharide effects on small mesenteric arteries. Life Sciences 71(17): 1997-2014
Gazzaruso, C.; Bruno, R.; Garzaniti, A.; Giordanetti, S.; Fratino, P.; Sacchi, P.; Filice, G. 2003: Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. Journal of Hypertension 21(7): 1377-1382
Lin, H.; Bermudez, O.I.; Falcon, L.M.; Tucker, K.L. 2002: Hypertension among Hispanic elders of a Caribbean origin in Massachusetts. Ethnicity and Disease 12(4): 499-507
Koura, M., R.; Shatat, H., Z.; Shama, M., E. 2000: Hypertension among non-working women in an underprivileged area in Alexandria. Journal of the Medical Research Institute 21(4): 60-72
Kozer, E.; Lahat, E.; Berkovitch, M. 1999: Hypertension and abdominal pain: uncommon presentation after exposure to a pine caterpillar. Toxicon: Official Journal of the International Society on Toxinology 37(12): 1797-1801
Schindler, R.; Tanriver, Y.; Frei, U. 2000: Hypertension and allograft nephropathy-cause, consequence, or both?. Nephrology Dialysis Transplantation 15(1): 8-10
Bell, D.S. 2000: Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. New England Journal of Medicine 343(8): 580
Nyklícek, I.; Vingerhoets, A.J.; Van Heck, G.L. 2001: Hypertension and appraisal of physical and psychological stressors. Journal of Psychosomatic Research 50(5): 237-244
Rahman, M.; Tondel, M.; Ahmad, S.A.; Chowdhury, I.A.; Faruquee, M.H.; Axelson, O. 1999: Hypertension and arsenic exposure in Bangladesh. Hypertension 33(1): 74-78
Arnett, D.K.; Boland, L.L.; Evans, G.W.; Riley, W.; Barnes, R.; Tyroler, H.A.; Heiss, G. 2000: Hypertension and arterial stiffness: the Atherosclerosis Risk in Communities Study. ARIC Investigators. American Journal of Hypertension 13(4 Pt 1): 317-323
Zucchelli, P.C. 2002: Hypertension and atherosclerotic renal artery stenosis: diagnostic approach. Journal of the American Society of Nephrology: Jasn 13(Suppl): S184-S186
Yeung, M.Y.; Smyth, J.P. 2000: Hypertension and bradycardia associated with high-dose dexamethasone in a premature infant with borderline hyponatraemia. Australian Journal of Hospital Pharmacy 30(5): 205-207
De Leeuw, F.-E.; de Groot, J.C.; Oudkerk, M.; Witteman, J.C.M.; Hofman, A.; van Gijn, J.; Breteler, M.M.B. 2002: Hypertension and cerebral white matter lesions in a prospective cohort study. Brain: a Journal of Neurology 125(Part 4): 765-772
Semplicini, A.; Maresca, A.; Sartori, M.; Calo, L.; Pessina, A., C. 2001: Hypertension and cerebrovascular diseases: A specific role of vascular protection for the prevention of dementia. Journal of Cardiovascular Pharmacology 38(Suppl 2): S79-S82
Tomei, F.; Fantini, S.; Tomao, E.; Baccolo, T.P.; Rosati, M.V. 2000: Hypertension and chronic exposure to noise. Archives of Environmental Health 55(5): 319-325
Prisant, L.M. 2001: Hypertension and chronotherapy: Shifting the treatment paradigm. American Journal of Hypertension 14(9 Pt 2): 277s-279s
Fujishima, M.; Tsuchihashi, T. 1999: Hypertension and dementia. Clinical and Experimental Hypertension 21(5-6): 927-935
Leonetti, G.; Lonati, L.; Cuspidi, C. 2002: Hypertension and diabetes in women. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 20(2): S23-S25
Deedwania, P.C. 2000: Hypertension and diabetes: new therapeutic options. Archives of Internal Medicine 160(11): 1585-1594
Parving, H.H. 2001: Hypertension and diabetes: The scope of the problem. Blood Pressure. Supplement 2: 25-31
Gillow, J.T.; Gibson, J.M.; Dodson, P.M. 1999: Hypertension and diabetic retinopathy--what's the story?. British Journal of Ophthalmology 83(9): 1083-1087
Hörl, M.P.; Hörl, W.H. 2003: Hypertension and dialysis. Kidney and Blood Pressure Research 26(2): 76-81
El-Khashab, O. 2002: Hypertension and end-stage renal disease in the developing world. Artificial Organs 26(9): 765-766
Yang, R.; Powell-Braxton, L.; Ogaoawara, A.K.; Dybdal, N.; Bunting, S.; Ohneda, O.; Jin, H. 1999: Hypertension and endothelial dysfunction in apolipoprotein e knockout mice. Arteriosclerosis Thrombosis and Vascular Biology 19(11): 2762-2768
Lewis, V.E.; Peat, D.S.; Tizard, E.J. 2001: Hypertension and facial palsy in middle aortic syndrome. Archives of Disease in Childhood 85(3): 240-241
Bardage, C.; Isacson, D.G. 2001: Hypertension and health-related quality of life. an epidemiological study in Sweden. Journal of Clinical Epidemiology 54(2): 172-181
Soler, M.; Chatenoud, L.; Negri, E.; Parazzini, F.; Franceschi, S.; la Vecchia, C. 1999: Hypertension and hormone-related neoplasms in women. Hypertension 34(2): 320-325
Sekiguchi, F.; Miyake, Y.; Hirakawa, A.; Nakahira, T.; Yamaoka, M.; Shimamura, K.; Yamamoto, K.; Sunano, S. 2001: Hypertension and impairment of endothelium-dependent relaxation of arteries from spontaneously hypertensive and L-NAME-treated Wistar rats. Journal of Smooth Muscle Research 37(2): 67-79
Itoh, H.; Doi, K.; Tanaka, T.; Fukunaga, Y.; Hosoda, K.; Inoue, G.; Nishimura, H.; Yoshimasa, Y.; Yamori, Y.; Nakao, K. 1999: Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma. Clinical and Experimental Pharmacology and Physiology 26(7): 558-560
Edwards, E.; King, J.A.; Fray, J. 2000: Hypertension and insulin resistant models have divergent propensities to learned helpless behavior in rodents. American Journal of Hypertension 13(6 Pt 1): 659-665
Lai, S.W.; Li, T.C.; Lin, C.C.; Tan, C.K.; Ng, K.C.; Lai, M.M.; Liu, C.S. 2001: Hypertension and its related factors in Taiwanese elderly people. Yale Journal of Biology and Medicine 74(2): 89-94
Maison, P.; Byrne, C.D.; Hales, C.N.; Wareham, N.J. 2000: Hypertension and its treatment influence changes in fasting nonesterified fatty acid concentrations: A link between the sympathetic nervous system and the metabolic syndrome?. Metabolism, Clinical and Experimental 49(1): 81-87
Fernández-Fresnedo, G.; Palomar, R.; Escallada, R.; Martín de Francisco, A.L.; Cotorruelo, J.G.; Zubimendi, J.A.; Sanz de Castro, S.; Ruiz, J.C.; Rodrigo, E.; Arias, M. 2001: Hypertension and long-term renal allograft survival: effect of early glomerular filtration rate. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(Suppl): 105-109
Watson, A.R. 2003: Hypertension and multicystic dysplastic kidney. Pediatric Nephrology 18(10): 1077
Djordjevic, V. 2001: Hypertension and nephropathy in diabetes mellitus: What is inherited and what is acquired?. Nephrology Dialysis Transplantation 16(Suppl 6): 92-93
Kimura, K.; Minematsu, K.; Yonemura, K.; Koga, M.; Yasaka, M.; Yamaguchi, T. 2001: Hypertension and neurovascular compression of the left lateral medulla oblongata in ischemic stroke. European Neurology 46(2): 70-74
Rappelli, A. 2002: Hypertension and obesity after the menopause. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 20(2): S26-S28
Nyklícek, I.; Vingerhoets, A.J.; Van Heck, G.L. 1999: Hypertension and pain sensitivity: Effects of gender and cardiovascular reactivity. Biological Psychology 50(2): 127-142
Mitsnefes, M.; Ho, P-Leung.; McEnery, P.T. 2003: Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Journal of the American Society of Nephrology: Jasn 14(10): 2618-2622
Maschio, G.; Oldrizzi, L.; Marcantoni, C.; Rugiu, C. 2000: Hypertension and progression of renal disease. Journal of Nephrology 13(3): 225-227
Lunetta, M.; Barbagallo, A.; Crimi, S.; Di Mauro, M.; Sangiorgio, L.; Mughini, L. 1998: Hypertension and related risk factors in type 2 diabetes mellitus. Panminerva Medica 40(3): 169-173
Jones, C.A. 2003: Hypertension and renal dysfunction: NHANES III. Journal of the American Society of Nephrology: Jasn 14(7 Suppl 2): S71-S75
Kennefick, T.M.; Al-Nimri, M.A.; Oyama, T.T.; Thompson, M.M.; Kelly, F.J.; Chapman, J.G.; Anderson, S. 1999: Hypertension and renal injury in experimental polycystic kidney disease. Kidney International 56(6): 2181-2190
Spence, J.David 2002: Hypertension and stroke. Canadian Journal of Neurological Sciences 29(2): 113-114
Schrader, J.; Roethemeyer, M.; Lueders, S.; Kollmann, K. 1998: Hypertension and stroke - rationale behind the ACCESS trial. Basic Research in Cardiology 93(Suppl 2): 69-78
Chatellier, G.; Colombet, I.; Dreau, H. 1999: Hypertension and stroke: The need for improved prevention strategies. Revue Neurologique (Paris) 155(9): 670-676
Messerli, F.H. 1999: Hypertension and sudden cardiac death. American Journal of Hypertension 12(12 part 3): 181S-188S
Light, K.C. 2001: Hypertension and the reactivity hypothesis: the next generation. Psychosomatic Medicine 63(5): 744-746
Quinkler, M.; Stewart, P.M. 2003: Hypertension and the cortisol-cortisone shuttle. Journal of Clinical Endocrinology and Metabolism 88(6): 2384-2392
Björntorp, P.; Holm, G.; Rosmond, R.; Folkow, B. 2000: Hypertension and the metabolic syndrome: closely related central origin?. Blood Pressure 9(2-3): 71-82
Rothermund, L.; Paul, M. 1998: Hypertension and the renin-angiotensin system--evidence from genetic and transgenic studies. Basic Research in Cardiology 93(Suppl): 1-6
Soranno, D.; Prasad, V.; David, R.; Oberfield, S.; Greco, A.; Sivaraman, N.; Drucker, W. 1999: Hypertension and virilization caused by a unique desoxycorticosterone- and androgen-secreting adrenal adenoma. Journal of Pediatric Endocrinology and Metabolism: Jpem 12(2): 215-220
Tangredi, J.F.; Buxton, I.L. 2001: Hypertension as a complication of topical testosterone therapy. Annals of PharmacoTherapy 35(10): 1205-1207
Arai, H.; Saitoh, S.; Matsumoto, T.; Makita, F.; Mitsugi, S.; Yuasa, K.; Takagi, H.; Mori, M. 1999: Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma. Journal of Gastroenterology 34(4): 530-534
Savazzi, G.M.; Cusmano, F.; Bergamaschi, E.; Vinci, S.; Allegri, L.; Garini, G. 1999: Hypertension as an etiopathological factor in the development of cerebral atrophy in hemodialyzed patients. Nephron 81(1): 17-24
Valderrábano, F.; Gómez-Campderá, F.; Jones, E.H. 1998: Hypertension as cause of end-stage renal disease: Lessons from international registries. Kidney International. Supplement 68: S60-S66
Karim, M.Y.; Alba, P.; Tungekar, M.F.; Abbs, I.C.; Khamashta, M.A.; Hughes, G.R.V.; Hunt, B.J. 2002: Hypertension as the presenting feature of the antiphospholipid syndrome. Lupus 11(4): 253-256
Pandey, K.N.; Oliver, P.M.; Maeda, N.; Smithies, O. 1999: Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140(11): 5112-5119
Snodgrass, W.T. 2000: Hypertension associated with multicystic dysplastic kidney in children. Journal of Urology 164(2): 472
Glodny, B.; Cromme, S.; Reimer, P.; Lennarz, M.; Winde, G.; Vetter, H. 2000: Hypertension associated with multiple renal arteries may be renin-dependent. Journal of Hypertension 18(10): 1437-1444
Sawada, K.; Naiki, M.; Yago, H.; Matsushita, K.; Ohtsuki, T.; Kitagawa, K.; Matsumoto, M.; Hori, M. 2003: Hypertension associated with reduced plasma thrombomodulin levels and a hypercoagulable state in rats. Clinical and Experimental Hypertension 25(2): 73-84
Ren, J.; Brown, R.A. 1999: Hypertension augments ethanol-induced depression of cell shortening and intracellular Ca(2+) transients in adult rat ventricular myocytes. Biochemical and Biophysical Research Communications 261(1): 202-208
Stewart, J.C.; France, C.R.; Sheffield, D. 2003: Hypertension awareness and pain reports: data from the NHANES III. Annals of Behavioral Medicine: a Publication of the Society of Behavioral Medicine 26(1): 8-14
Hashim, T.J.; Anokute, C.C.; Al-Shammary, F.J.; Khoja, T.A.; Saeed, A.A.; Khan, S.B. 1998: Hypertension awareness: Treatment and control among adult hypertensives. Saudi Medical Journal 19(6): 707-712
Lunt, D.W.; Edwards, P.R.; Steyn, K.; Lombard, C.J.; Fehrsen, G.S. 1998: Hypertension care at a Cape Town community health centre. South African Medical Journal 88(5): 544-548
Siddiqui, S.; Ogbeide, D.O.; Karim, A.; Al-Khalifa, I. 2001: Hypertension control in a community health centre at Riyadh, Saudi Arabia. Saudi Medical Journal 22(1): 49-52
Neutel, J.M.; Smith, D.H.G. 1999: Hypertension control: Multifactorial contributions. American Journal of Hypertension 12(12 part 1-2): 164S-169S
Levy, D.; Merz, C.N.; Cody, R.J.; Fouad-Tarazi, F.M.; Francis, C.K.; Pfeffer, M.A.; Scott, N.A.; Swan, H.J.; Taylor, M.P.; Weinberger, M.H. 1999: Hypertension detection, treatment and control: A call to action for cardiovascular specialists. Journal of the American College of Cardiology 34(4): 1360-1362
Chen, J.; Kuhlencordt, P.J.; Astern, J.; Gyurko, R.; Huang, P.L. 2001: Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation 104(20): 2391-2394
Guimarães, S.; Morato, M.; Sousa, T.; Albino-Teixeira, Aónio. 2003: Hypertension due to blockade of adenosine receptors. Pharmacology and Toxicology 92(4): 160-162
Miyazawa, K.; Kigoshi, T.; Nakano, S.; Kobayashi, Y.; Suzuki, K.; Tsugawa, R.; Uchida, K. 1998: Hypertension due to coexisting pheochromocytoma and aldosterone-producing adrenal cortical adenoma. American Journal of Nephrology 18(6): 547-550
Riccialdelli, L.; Arnaldi, G.; Giacchetti, G.; Pantanetti, P.; Mantero, F. 2001: Hypertension due to renal artery occlusion in a patient with antiphospholipid syndrome. American Journal of Hypertension 14(1): 62-65
Rodriguez-Porcel, M.; Lerman, A.; Herrmann, J.; Schwartz, R.S.; Sawamura, T.; Condorelli, M.; Napoli, C.; Lerman, L.O. 2003: Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovascular Research 58(1): 213-221
Tu, K.; Mamdani, M.M.; Tu, J.V. 2002: Hypertension guidelines in elderly patients: Is anybody listening?. American Journal of Medicine 113(1): 52-58
Alderman, M.H.; Furberg, C.D.; Kostis, J.B.; Laragh, J.H.; Psaty, B.M.; Ruilope, L.M.; Volpe, M.; Jackson, R. 2002: Hypertension guidelines: Criteria that might make them more clinically useful. American Journal of Hypertension 15(10 Pt 1): 917-923
Mbaya, V.B. 1998: Hypertension in east Africans and others of African descent: a review. East African Medical Journal 75(5): 300-303
Drummond, P.M.; Moghal, N.E.; Coulthard, M.G. 2001: Hypertension in Henoch-Schönlein purpura with minimal urinary findings. Archives of Disease in Childhood 84(2): 163-164
Steyn, K.; Gaziano, T.A.; Bradshaw, D.; Laubscher, R.; Fourie, J. 2001: Hypertension in South African adults: results from the Demographic and Health Survey, 1998. Journal of Hypertension 19(10): 1717-1725
Kashiwagi, M.; Breymann, C.; Huch, R.; Huch, A. 2002: Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Archives of Gynecology and Obstetrics 267(1): 54-56
Semplicini, A.; Maresca, A.; Boscolo, G.; Sartori, M.; Rocchi, R.; Giantin, V.; Forte, P.Luigi.; Pessina, A.C. 2003: Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor?. Archives of Internal Medicine 163(2): 211-216
Bath, P.; Boysen, G.; Donnan, G.; Kaste, M.; Lees, K.R.; Olsen, T.; Overgaard, K.; Sandercock, P.; Wahlgren, N.G. 2001: Hypertension in acute stroke: what to do?. Stroke 32(7): 1697-1698
Shome, B.; Nadeau, J.; Blevins, L.S. 2002: Hypertension in an adolescent boy. American Journal of the Medical Sciences 323(4): 227-230
Danziger, R.S. 2001: Hypertension in an anthropological and evolutionary paradigm. Hypertension 38(1): 19-22
Marro, M.L.; Scremin, O.U.; Jordan, M.C.; Huynh, L.; Porro, F.; Roos, K.P.; Gajovic, S.; Baralle, F.E.; Muro, A.F. 2000: Hypertension in beta-adducin-deficient mice. Hypertension 36(3): 449-453
Stein, C.M.; Lang, C.C.; Xie, H.G.; Wood, A.J. 2001: Hypertension in black people: study of specific genotypes and phenotypes will provide a greater understanding of interindividual and interethnic variability in blood pressure regulation than studies based on race. Pharmacogenetics 11(2): 95-110
Coatmellec-Taglioni, G.; Dausse, J.P.; Ribière, C.; Giudicelli, Y. 2000: Hypertension in cafeteria-fed rats: alterations in renal alpha2-adrenoceptor subtypes. American Journal of Hypertension 13(5 Pt 1): 529-534
Vogt, B.A. 2001: Hypertension in children and adolescents: Definition, pathophysiology, risk factors, and long-term sequelae. Current Therapeutic Research 62(4): 283-297
Bianchi, G. 2000: Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 15(Suppl 5): 105-110
Fuentes, R.; Ilmaniemi, N.; Laurikainen, E.; Tuomilehto, J.; Nissinen, A. 2000: Hypertension in developing economies: a review of population-based studies carried out from 1980 to 1998. Journal of Hypertension 18(5): 521-529
Bellinghieri, G.; Santoro, D.; Mazzaglia, G.; Savica, V. 1999: Hypertension in dialysis patients. Mineral and Electrolyte Metabolism 25(1-2): 84-89
D'Amico, M.; Locatelli, F. 2002: Hypertension in dialysis: pathophysiology and treatment. Journal of Nephrology 15(4): 438-445
Tenenbaum, A.; Fisman, E.Z.; Boyko, V.; Goldbourt, U.; Graff, E.; Shemesh, J.; Shotan, A.; Reicher-Reiss, H.; Behar, S.; Motro, M. 1999: Hypertension in diet versus pharmacologically treated diabetics: mortality over a 5-year follow-up. Hypertension 33(4): 1002-1007
Aronow, W.S. 1999: Hypertension in elderly patients: treatment reduces mortality, but is underused. Cleveland Clinic Journal of Medicine 66(8): 487-493
Cruickshank, J.K.; Mbanya, J.C.; Wilks, R.; Balkau, B.; Forrester, T.; Anderson, S.G.; Mennen, L.; Forhan, A.; Riste, L.; McFarlane-Anderson, N. 2001: Hypertension in four African-origin populations: current 'Rule of Halves', quality of blood pressure control and attributable risk of cardiovascular disease. Journal of Hypertension 19(1): 41-46
Eisen, H.J. 2003: Hypertension in heart transplant recipients: More than just cyclosporine. Journal of the American College of Cardiology 41(3): 433-434
Amar, J.; Vaur, L.; Perret, M.; Bailleau, C.; Etienne, S.; Chamontin, B. 2002: Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study). Journal of Hypertension 20(4): 779-784
Hernelahti, M.; Kujala, U.M.; Kaprio, J.; Karjalainen, J.; Sarna, S. 1998: Hypertension in master endurance athletes. Journal of Hypertension 16(11): 1573-1577
August, P. 1999: Hypertension in men. Journal of Clinical Endocrinology and Metabolism 84(10): 3451-3454
Kotelevtsev, Y.; Brown, R.W.; Fleming, S.; Kenyon, C.; Edwards, C.R.; Seckl, J.R.; Mullins, J.J. 1999: Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. Journal of Clinical Investigation 103(5): 683-689
Tipnis, U.R.; Li, S. 2001: Hypertension in normotensive and hypertensive rats by spermine ingestion. Cytobios 106(Suppl): 85-98
Rhoades, D.A.; Buchwald, D. 2003: Hypertension in older urban Native-American primary care patients. Journal of the American Geriatrics Society 51(6): 774-781
Fletcher, E.C. 2000: Hypertension in patients with sleep apnoea, a combined effect?. Thorax 55(9): 726-728
Repke, J.T.; Power, M.L.; Holzman, G.B.; Schulkin, J. 2002: Hypertension in pregnancy and preeclampsia. Knowledge and clinical practice among obstetrician-gynecologists. Journal of Reproductive Medicine 47(6): 472-476
Seely, E.W. 1999: Hypertension in pregnancy: a potential window into long-term cardiovascular risk in women. Journal of Clinical Endocrinology and Metabolism 84(6): 1858-1861
Garovic, V.D. 2000: Hypertension in pregnancy: diagnosis and treatment. Mayo Clinic Proceedings 75(10): 1071-1076
Kantachuvessiri, A. 2002: Hypertension in public health. Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 425-431
Holm, Tørn.; Aukrust, Pål.; Aagaard, E.; Ueland, T.; Haugstad, T.S.; Kjekshus, J.; Simonsen, S.; Frøland, S.S.; Gullestad, L.; Andreassen, A.K. 2002: Hypertension in relation to nitric oxide, asymmetric dimethylarginine, and inflammation: different patterns in heart transplant recipients and individuals with essential hypertension. Transplantation 74(10): 1395-1400
Kendall, M.J. 1998: Hypertension in the elderly. Basic Research in Cardiology 93(Suppl 2): 43-46
Maruenda, J.; Bhatnagar, V.; Lowenthal, D.T. 1999: Hypertension in the elderly with coexisting benign prostatic hyperplasia. Urology 53(3 Suppl 3a): 7
Prisant, L.M.; Moser, M. 2000: Hypertension in the elderly: can we improve results of therapy?. Archives of Internal Medicine 160(3): 283-289
Salem, M.M. 1999: Hypertension in the haemodialysis population: any relationship to 2-years survival?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(1): 125-128
Watkinson, M. 2002: Hypertension in the newborn baby. Archives of Disease in Childhood. Fetal and Neonatal Edition 86(2): F78-F81
Zeier, M.; Mandelbaum, A.; Ritz, E. 1998: Hypertension in the transplanted patient. Contributions to Nephrology 124: 146-57; Discussion 158-65
Lagneux, C.; Joyeux, M.; Bricca, G.; Demenge, P.; Ribuot, C. 2000: Hypertension in transgenic (mREN2)27 rats is not associated with the presence of B1 receptors. Fundamental and Clinical Pharmacology 14(2): 119-123
Forette, B. 1999: Hypertension in very old subjects. Clinical and Experimental Hypertension 21(5-6): 917-925
August, P.; Oparil, S. 1999: Hypertension in women. Journal of Clinical Endocrinology and Metabolism 84(6): 1862-1866
Morse, S.A.; Dang, A.; Thakur, V.; Zhang, R.; Reisin, E. 2003: Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment. American Journal of the Medical Sciences 325(4): 194-201
Everson, S.A.; Kaplan, G.A.; Goldberg, D.E.; Salonen, J.T. 2000: Hypertension incidence is predicted by high levels of hopelessness in Finnish men. Hypertension 35(2): 561-567
Schindler, R.; Tullius, S.G.; Tanriver, Y.; Noack, K.; Qun, Y.; Jürgensen, J.-S.; Frei, U. 2003: Hypertension increases expression of growth factors and MHC Ii in chronic allograft nephropathy. Kidney International 63(6): 2302-2308
Elsheikh, M.; Casadei, B.; Conway, G.S.; Wass, J.A. 2001: Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clinical Endocrinology 54(1): 69-73
Di Paolo, S.; Stallone, G.; Schena, A.; Infante, B.; Gesualdo, L.; Paolo Schena, F. 2002: Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 73(4): 623-627
Peschke, B.; Scheuermann, E.H.; Geiger, H.; Bölscher, S.; Kachel, H.G.; Lenz, T. 1999: Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. Clinical Nephrology 51(5): 290-295
Burchardt, M.; Burchardt, T.; Baer, L.; Kiss, A.J.; Pawar, R.V.; Shabsigh, A.; de la Taille, A.; Hayek, O.R.; Shabsigh, R. 2000: Hypertension is associated with severe erectile dysfunction. Journal of Urology 164(4): 1188-1191
Banegas, Jé.R.; Rodríguez-Artalejo, F.; Ruilope, L.M.; Graciani, A.; Luque, M.; de la Cruz-Troca, J.J.; García-Robles, R.; Tamargo, J.; Rey-Calero, J. 2002: Hypertension magnitude and management in the elderly population of Spain. Journal of Hypertension 20(11): 2157-2164
Hansson, L. 2002: Hypertension management in 2002: Where have we been? Where might we be going?. American Journal of Hypertension 15(10 Pt 2): 101s-107s
Edwards, P.R.; Steyn, K.; Walters, L.; Smart, A.; Gammon, S.; Lombard, C.J. 1999: Hypertension management of medical aid patients attending private practices. South African Medical Journal 89(2): 160-164
Johansson, B.B. 1999: Hypertension mechanisms causing stroke. Clinical and Experimental Pharmacology and Physiology 26(7): 563-565
Baggot, M.G. 1999: Hypertension muscular/endocameral: a universal idiopathic disorder constituting/causing various arthropathies including those of the universal contractile chamber and their sequelae. Medical Hypotheses 53(4): 333-337
Sampaio, R.C.; Tanus-Santos, J.E.; Melo, S.E.S.F.C.; Hyslop, S.; Franchini, K.G.; Luca, I.M.; Moreno, H. 2002: Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats. Chest 122(4): 1412-1420
Wolf-Maier, K.; Cooper, R.S.; Banegas, Jé.R.; Giampaoli, S.; Hense, H-Werner.; Joffres, M.; Kastarinen, M.; Poulter, N.; Primatesta, P.; Rodríguez-Artalejo, F.; Stegmayr, B.; Thamm, M.; Tuomilehto, J.; Vanuzzo, D.; Vescio, F. 2003: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289(18): 2363-2369
Hartley, T.R.; Sung, B.H.; Pincomb, G.A.; Whitsett, T.L.; Wilson, M.F.; Lovallo, W.R. 2000: Hypertension risk status and effect of caffeine on blood pressure. Hypertension 36(1): 137-141
Basiri, A.; Salim, N.S.; Shadpour, P. 2002: Hypertension secondary to an adrenal pseudocyst cured by laparoscopic partial adrenalectomy. Journal of Endourology 16(9): 689-691
Parati, G.; Mancia, G. 2002: Hypertension staging through ambulatory blood pressure monitoring. Hypertension 40(6): 792-794
Su, T.C.; Jeng, J.S.; Chien, K.L.; Sung, F.C.; Hsu, H.C.; Lee, Y.T. 2001: Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke 32(10): 2265-2271
Hayslett, J.A.; Eichner, J.E.; Yeh, J.L.; Wang, W.; Henderson, J.; Devereux, R.B.; Welty, T.K.; Fabsitz, R.R.; Howard, B.V.; Lee, E.T. 2001: Hypertension treatment patterns in American Indians: The strong heart study. American Journal of Hypertension 14(9 Pt 1): 950-956
Tuhrim, S.; Levine, S.R. 2002: Hypertension+MRi changes=impaired cognition. Journal of Neurology Neurosurgery and Psychiatry 72(6): 690
Ben-Yehuda, O. 2003: Hypertension, angiotensin II, aldosterone, and race. Journal of the American College of Cardiology 41(7): 1156-1158
Shapiro, J.A.; Williams, M.A.; Weiss, N.S.; Stergachis, A.; LaCroix, A.Z.; Barlow, W.E. 1999: Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. American Journal of Epidemiology 149(6): 521-530
Hölttä, T.; Happonen, J.M.; Rönnholm, K.; Fyhrquist, F.; Holmberg, C. 2001: Hypertension, cardiac state, and the role of volume overload during peritoneal dialysis. Pediatric Nephrology 16(4): 324-331
Hennis, A.; Wu, S-Yuh.; Nemesure, B.; Leske, M.Cristina. 2003: Hypertension, diabetes, and longitudinal changes in intraocular pressure. Ophthalmology 110(5): 908-914
Fitzpatrick, A.L.; Daling, J.R.; Furberg, C.D.; Kronmal, R.A.; Weissfeld, J.L. 2001: Hypertension, heart rate, use of antihypertensives, and incident prostate cancer. Annals of Epidemiology 11(8): 534-542
Sowers, J.R.; Lester, M. 2000: Hypertension, hormones, and aging. Journal of Laboratory and Clinical Medicine 135(5): 379-386
Salvi, F.; Mascalchi, M.; Bortolotti, C.; Meletti, S.; Plasmati, R.; Rubboli, G.; Stecchi, S.; Villari, N.; Calbucci, F.; Tassinari, C.A. 2000: Hypertension, hyperekplexia, and pyramidal paresis due to vascular compression of the medulla. Neurology 55(9): 1381-1384
Skoog, I.; Gustafson, D. 2003: Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurological Research 25(6): 675-680
Ishibashi, M.; Egashira, K.; Hiasa, K.-i.; Inoue, S.; Ni, W.; Zhao, Q.; Usui, M.; Kitamoto, S.; Ichiki, T.; Takeshita, A. 2002: Antiinflammatory and antiarteriosclerotic effects of pioglitazone. Hypertension 40(5): 687-693
Muiesan, M.L.; Agabiti Rosei, E. 1999: Hypertension, quantitative benefits of treatment: Optimal intervention points and management in aircrew. European Heart Journal 1(Suppl D): D32-D36
Moore, T.L.; Killiany, R.J.; Rosene, D.L.; Prusty, S.; Hollander, W.; Moss, M.B. 2003: Hypertension-induced changes in monoamine receptors in the prefrontal cortex of rhesus monkeys. Neuroscience 120(1): 177-189
Yang, H.; Francis, S.C.; Sellers, K.; DeBarros, M.; Sun, C.; Sumners, C.; Ferrario, C.M.; Katovich, M.J.; Muro, Aés.F.; Raizada, M.K. 2002: Hypertension-linked decrease in the expression of brain gamma-adducin. Circulation Research 91(7): 633-639
Guasti, L.; Zanotta, D.; Mainardi, L.T.; Petrozzino, M.R.; Grimoldi, P.; Garganico, D.; Diolisi, A.; Gaudio, G.; Klersy, C.; Grandi, A.M.; Simoni, C.; Cerutti, S. 2002: Hypertension-related hypoalgesia, autonomic function and spontaneous baroreflex sensitivity. Autonomic Neuroscience: Basic and Clinical 99(2): 127-133
Tribulova, N.; Okruhlicova, L.; Novakova, S.; Pancza, D.; Bernatova, I.; Pechanova, O.; Weismann, P.; Manoach, M.; Seki, S.; Mochizuki, S. 2002: Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K(+)-induced lethal arrhythmias in isolated rat heart. Experimental Physiology 87(2): 195-205
Johnson, R.J.; Rodríguez-Iturbe, B.; Schreiner, G.F.; Herrera-Acosta, J. 2002: Hypertension: a microvascular and tubulointerstitial disease. Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 20(3): S1-S7
Himmelmann, A. 1999: Hypertension: An important precursor of heart failure. Blood Pressure 8(5-6): 253-260
Frohlich, E.D. 2001: Hypertension: our major challenges. Hypertension 38(5): 990-991
Kotlikoff, M.; Hall, I. 2003: Hypertension: beta testing. Journal of Clinical Investigation 112(5): 654-656
Troshin, V.D. 2002: Hypertensive angioencephalopathies. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(11): 14-16
Tan, S.H.; Ng, P.Y.; Yeo, T.T.; Wong, S.H.; Ong, P.L.; Venketasubramanian, N. 2001: Hypertensive basal ganglia hemorrhage: A prospective study comparing surgical and nonsurgical management. Surgical Neurology 56(5): 287-92; discussion 292-3
Sabbatini, M.; Tomassoni, D.; Amenta, F. 2001: Hypertensive brain damage: Comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats. Mechanisms of Ageing and Development 122(16): 2085-2105
Liao, P-Yuan.; Lee, C-Chang.; Chen, C-Yu. 2015: Hypertensive brain stem encephalopathy. American Journal of Emergency Medicine 33(1): 131.E5-7
Thambisetty, M.; Biousse, V.; Newman, N.J. 2003: Hypertensive brainstem encephalopathy: Clinical and radiographic features. Journal of the Neurological Sciences 208(1-2): 93-99
Chang, G.Y.; Keane, J.R. 1999: Hypertensive brainstem encephalopathy: three cases presenting with severe brainstem edema. Neurology 53(3): 652-654
Vagaonescu, T.D.; Saadia, D.; Tuhrim, S.; Phillips, R.A.; Kaufmann, H. 2000: Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355(9205): 725-726
Liliang, P.C.; Liang, C.L.; Lu, C.H.; Chang, H.W.; Cheng, C.H.; Lee, T.C.; Chen, H.J. 2001: Hypertensive caudate hemorrhage prognostic predictor, outcome, and role of external ventricular drainage. Stroke 32(5): 1195-1200
Lammie, G.Alistair. 2002: Hypertensive cerebral small vessel disease and stroke. Brain Pathology 12(3): 358-370
Frye, C.B.; Vance, M.A. 2000: Hypertensive crisis and myocardial infarction following massive clonidine overdose. Annals of PharmacoTherapy 34(5): 611-615
Wilson, B.J.; Watson, M.S.; Prescott, G.J.; Sunderland, S.; Campbell, D.M.; Hannaford, P.; Smith, W.C.S. 2003: Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Bmj 326(7394): 845
Sibai, B.M.; Hauth, J.; Caritis, S.; Lindheimer, M.D.; Macpherson, C.; Klebanoff, M.; Vandorsten, J.P.; Landon, M.; Miodovnik, M.; Paul, R.; Meis, P.; Thurnau, G.; Dombrowski, M.; Roberts, J.; Mcnellis, D. 2000: Hypertensive disorders in twin versus singleton gestations. American Journal of Obstetrics and Gynecology 182(4): 938-942
Buga, G.A.; Lumu, S.B. 1999: Hypertensive disorders of pregnancy at Umtata General Hospital: perinatal and maternal outcomes. East African Medical Journal 76(4): 217-222
Pearson, E.R.; D'Souza, R.J.; Hamilton-Wood, C.; Nicholls, A.J.; Beaman, M. 1999: Hypertensive encephalopathy and nephrotic syndrome: a possible link?. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 14(7): 1750-1752
Amin-Hanjani, S.; Schwartz, R.B.; Sathi, S.; Stieg, P.E. 1999: Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 44(5): 1113-1116
Pijnenburg, M.W.; Zweens, M.J.; Bink, M.T.; Reitsma, W.C.; Odink, R.J. 1999: Hypertensive encephalopathy in a patient with neonatal thyrotoxicosis. European Journal of Pediatrics 158(10): 789-790
Tang-Wai, D.F.; Phan, T.G.; Wijdicks, E.F. 2001: Hypertensive encephalopathy presenting with thunderclap headache. Headache 41(2): 198-200
Haubrich, C.; Mull, M.; Hecklinger, J.; Noth, J.; Block, F. 2001: Hypertensive encephalopathy with a focal cortical edema in MRI. Journal of Neurology 248(10): 900-902
Pavlakis, S.G.; Frank, Y.; Chusid, R. 1999: Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. Journal of Child Neurology 14(5): 277-281
Solinas, C.; Briellmann, R.S.; Harvey, A.S.; Mitchell, L.A.; Berkovic, S.F. 2003: Hypertensive encephalopathy: antecedent to hippocampal sclerosis and temporal lobe epilepsy?. Neurology 60(9): 1534-1536
Cooney, M.J.; Bradley, W.G.; Symko, S.C.; Patel, S.T.; Groncy, P.K. 2000: Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders--report of three cases. Radiology 214(3): 711-716
Behr, T.M.; Nerurkar, S.S.; Nelson, A.H.; Coatney, R.W.; Woods, T.N.; Sulpizio, A.; Chandra, S.; Brooks, D.P.; Kumar, S.; Lee, J.C.; Ohlstein, E.H.; Angermann, C.E.; Adams, J.L.; Sisko, J.; Sackner-Bernstein, J.D.; Willette, R.N. 2001: Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation 104(11): 1292-1298
Fu, S.; Cao, Y.; Li, Y.; Li, F.; Peng, Y.; Dong, L.; He, Y. 2002: Hypertensive epidemiology in Heilongjiang Province in China. Chinese Medical Journal 115(4): 498-501
Lip, G.Y.; Felmeden, D.C.; Li-Saw-Hee, F.L.; Beevers, D.G. 2000: Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?. European Heart Journal 21(20): 1653-1665
Qiu, Y.; Lin, Y.; Tian, X.; Luo, Q. 2003: Hypertensive intracranial hematomas: endoscopic-assisted keyhole evacuation and application of patent viewing dissector. Chinese Medical Journal 116(2): 195-199
Kinugawa, T.; Mori, M.; Ogino, K.; Endo, A.; Kato, M.; Kato, T.; Osaki, S.; Ohtahara, A.; Igawa, O.; Hisatome, I.; Shigemasa, C. 1999: Hypertensive left ventricular hypertrophy is linked to an enhanced catecholamine response to submaximal exercise. European Journal of Clinical Investigation 29(7): 594-602
Greenwood, J.P.; Scott, E.M.; Stoker, J.B.; Mary, D.A. 2001: Hypertensive left ventricular hypertrophy: Relation to peripheral sympathetic drive. Journal of the American College of Cardiology 38(6): 1711-1717
Perticone, F.; Maio, R.; Cosco, C.; Ceravolo, R.; Iacopino, S.; Chello, M.; Mastroroberto, P.; Tramontano, D.; Mattioli, P.L. 1999: Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovascular Research 43(1): 192-199
Engström, G.; Hedblad, B.; Janzon, L. 1999: Hypertensive men who exercise regularly have lower rate of cardiovascular mortality. Journal of Hypertension 17(6): 737-742
Rutkowski, B.; Tylicki, L.; Manitius, J.; Lysiak-Szydlowska, W. 1999: Hypertensive nephropathy - an increasing clinical problem. Mineral and Electrolyte Metabolism 25(1-2): 65-68
Marcantoni, C.; Ma, L-Jun.; Federspiel, C.; Fogo, A.B. 2002: Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney International 62(1): 172-180
Jeong, J-Hyang.; Yoon, S.Jin.; Kang, S.J.; Choi, K.Gyu.; Na, D.L. 2002: Hypertensive pontine microhemorrhage. Stroke 33(4): 925-929
Little, W.C. 2001: Hypertensive pulmonary oedema is due to diastolic dysfunction. European Heart Journal 22(21): 1961-1964
Newman, J.H.; Lane, K.B. 2000: Hypertensive pulmonary vascular disease: dawn of the age of prevention?. American Journal of Respiratory and Critical Care Medicine 162(6): 2020-2021
Krukoff, T.L.; Mactavish, D.; Jhamandas, J.H. 1999: Hypertensive rats exhibit heightened expression of corticotropin-releasing factor in activated central neurons in response to restraint stress. Brain Research. Molecular Brain Research 65(1): 70-79
Piccoli, G.B.; Anania, P.; Biancone, L.; Mezza, E.; Vischi, M.; Jeantet, A.; Rabbia, C.; Savio, D.; Rossatto, D.; Gai, M.; Perin, P.C.; Segoloni, G.P. 2001: Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 16(5): 1084-1085
Tracy, R.E.; Ishii, T. 2000: Hypertensive renovasculopathies and the rise of blood pressure with age in Japan and USA. International Urology and Nephrology 32(1): 109-117
Zicha, J.; Pechánová, O.; Dobesová, Z.; Kunes, J. 2003: Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats. Clinical Science 105(4): 483-489
Ha, J-Won.; Juracan, E.M.; Mahoney, D.W.; Oh, J.K.; Shub, C.; Seward, J.B.; Pellikka, P.A. 2002: Hypertensive response to exercise: A potential cause for new wall motion abnormality in the absence of coronary artery disease. Journal of the American College of Cardiology 39(2): 323-327
Wang, J.J.; Mitchell, P.; Leung, H.; Rochtchina, E.; Wong, T.Y.; Klein, R. 2003: Hypertensive retinal vessel wall signs in a general older population: the Blue Mountains Eye Study. Hypertension 42(4): 534-541
Duncan, B.B.; Wong, T.Y.; Tyroler, H.A.; Davis, C.E.; Fuchs, F.D. 2002: Hypertensive retinopathy and incident coronary heart disease in high risk men. British Journal of Ophthalmology 86(9): 1002-1006
Fogo, A.B. 2003: Hypertensive risk factors in kidney disease in African Americans. Kidney International. Supplement 2003(83): S17-S21
O'Sullivan, C.án.; Duggan, J.; Lyons, S.; Thornton, J.; Lee, M.; O'Brien, E. 2003: Hypertensive target-organ damage in the very elderly. Hypertension 42(2): 130-135
Abo-Zena, R.A.; Bobek, M.B.; Dweik, R.A. 2000: Hypertensive urgency induced by an interaction of mirtazapine and clonidine. Pharmacotherapy 20(4): 476-478
Luo, S.; Luo, C.; Yang, C.; Piao, Y.; Seguchi, H. 2000: Hyperthermal influence on intracellular free calcium concentration in cultured macrophages of mice. Acta Histochemica et Cytochemica 33(3): 195-200
Zeiner, A.; Holzer, M.; Sterz, F.; Schörkhuber, W.; Eisenburger, P.; Havel, C.; Kliegel, A.; Laggner, A.N. 2001: Hyperthermia after cardiac arrest is associated with an unfavorable neurologic outcome. Archives of Internal Medicine 161(16): 2007-2012
Tanvetyanon, T.; Dissin, J.; Selcer, U.M. 2001: Hyperthermia and chronic pancerebellar syndrome after cocaine abuse. Archives of Internal Medicine 161(4): 608-610
Kong, G.; Dewhirst, M.W. 1999: Hyperthermia and liposomes. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 15(5): 345-370
Ehlers, E.-M.; Kühnel, W.; Wiedemann, G.J. 2002: Hyperthermia and mafosfamide in a human-derived malignant pleural mesothelioma cell line. Journal of Cancer Research and Clinical Oncology 128(2): 65-72
Amichetti, M.; Romano, M.; Cristoforetti, L.; Valdagni, R. 2000: Hyperthermia and radiotherapy for inoperable squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 16(1): 85-93
Feyerabend, T.; Wiedemann, G.J.; Richter, E.; Hegewisch Becker, S. 1999: Hyperthermia as an adjunct to the standard treatment of neoplastic diseases: Few cures but some advances. Onkologie 22(2): 122-127
Thomas, G.; Souil, E.; Richard, M-Jeanne.; Saunier, B.; Polla, B.S.; Bachelet, M. 2002: Hyperthermia assists survival of astrocytes from oxidative-mediated necrotic cell death. Cellular and Molecular Biology 48(2): 191-198
Giombini, A.; Di Cesare, A.; Casciello, G.; Sorrenti, D.; Dragoni, S.; Gabriele, P. 2002: Hyperthermia at 434 MHz in the treatment of overuse sport tendinopathies: a randomised controlled clinical trial. International Journal of Sports Medicine 23(3): 207-211
Orihara, K.; Biro, S.; Hamasaki, S.; Eto, H.; Miyata, M.; Ikeda, Y.; Tei, C. 2002: Hyperthermia at 43 degrees C for 2h inhibits the proliferation of vascular smooth muscle cells, but not endothelial cells. Journal of Molecular and Cellular Cardiology 34(9): 1205-1215
Salomir, R.; Vimeux, F.C.; de Zwart, J.A.; Grenier, N.; Moonen, C.T. 2000: Hyperthermia by MR-guided focused ultrasound: Accurate temperature control based on fast MRI and a physical model of local energy deposition and heat conduction. Magnetic Resonance in Medicine 43(3): 342-347
Blasiak, J.; Widera, K.; Pertyński, T. 2003: Hyperthermia can differentially modulate the repair of doxorubicin-damaged DNA in normal and cancer cells. Acta Biochimica Polonica 50(1): 191-195
Ohizumi, Y.; Tama, Y.; Imamiya, S.; Akiba, T. 2000: Hyperthermia combined with re-irradiation for neck node metastasis from head and neck cancer. Tokai Journal of Experimental and Clinical Medicine 25(2): 61-67
Yakymovych, M.Y.; Yakymovych, I.A.; Tryndiak, V.P.; Stoika, R.S. 1999: Hyperthermia differentially induces apoptosis in murine L1210 leukemia cells sensitive and resistant to cisplatin. Eksperimental'naya Onkologiya 21(2): 154-156
Wachsberger, P.R.; Iliakis, G. 2000: Hyperthermia does not affect rejoining of DNA double-strand breaks in a cell-free assay. International Journal of Radiation Biology 76(3): 313-326
Park, T.S.; Seol, E.Y.; Park, H.W.; Kim, M.H. 2000: Hyperthermia effect on morphogenesis during mouse development. Korean Journal of Genetics 22(1): 35-42
Kong, G.; Braun, R.D.; Dewhirst, M.W. 2000: Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. Cancer Research 60(16): 4440-4445
Hermisson, M.; Weller, M. 2000: Hyperthermia enhanced chemosensitivity of human malignant glioma cells. Anticancer Research 20(3a): 1819-1823
Iwamoto, G.K.; Ainsworth, A.M.; Moseley, P.L. 1999: Hyperthermia enhances cytomegalovirus regulation of HIV-1 and TNF-alpha gene expression. American Journal of Physiology 277(5): L1051-L1056
Henry, K.R. 2003: Hyperthermia exacerbates and hypothermia protects from noise-induced threshold elevation of the cochlear nerve envelope response in the C57BL/6J mouse. Hearing Research 179(1-2): 88-96
Eikesdal, H.P.; Bjorkhaug, S.T.; Dahl, O. 2002: Hyperthermia exhibits anti-vascular activity in the s.c. BT4An rat glioma: lack of interaction with the angiogenesis inhibitor batimastat. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 18(2): 141-152
Thompson, H.J.; Tkacs, N.C.; Saatman, K.E.; Raghupathi, R.; Mcintosh, T.K. 2003: Hyperthermia following traumatic brain injury: A critical evaluation. Neurobiology of Disease 12(3): 163-173
Ohno, S.; Sumiyoshi, Y.; Mori, M.; Sugimachi, K. 2002: Hyperthermia for rectal cancer. Surgery 131(1 Suppl): S121-S127
Stein, U.; Rau, B.; Wust, P.; Walther, W.; Schlag, P.M. 1999: Hyperthermia for treatment of rectal cancer: Evaluation for induction of multidrug resistance gene (mdr1) expression. International Journal of Cancer 80(1): 5-12
Schueller, G.; Stift, A.; Friedl, J.; Dubsky, P.; Bachleitner-Hofmann, T.; Benkoe, T.; Jakesz, R.; Gnant, M. 2003: Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. International Journal of Oncology 22(6): 1397-1402
Gurkan Zorlu, C.; Eylem Seker Ari, P. 2003: Hyperthermia in gynecologic cancers. European Journal of Gynaecological Oncology 24(3-4): 282-286
Falk, M.H.; Issels, R.D. 2001: Hyperthermia in oncology. International Journal of Hyperthermia 17(1): 1-18
Van Der Zee, J.; Rietveld, P.J.M.; Broekmeyer Reurink, M.P.; Wielheesen, D.H.M.; Van Rhoon, G.C. 2002: Hyperthermia in recurrent breast cancer: From experimental oncology to standard practice. Eksperimental'naya Onkologiya 24(1): 45-50
Thong, W.Y.; Strickler, A.G.; Li, S.; Stewart, E.E.; Collier, C.L.; Vaughn, W.K.; Nussmeier, N.A. 2002: Hyperthermia in the forty-eight hours after cardiopulmonary bypass. Anesthesia and Analgesia 95(6): 1489-95 Table of Contents
Kilpatrick, M.M.; Lowry, D.W.; Firlik, A.D.; Yonas, H.; Marion, D.W. 2000: Hyperthermia in the neurosurgical intensive care unit. Neurosurgery 47(4): 850
Kubista, B.; Trieb, K.; Blahovec, H.; Kotz, R.; Micksche, M. 2002: Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis. Anticancer Research 22(2a): 789-792
Sharma, H.S.; Hoopes, P.J. 2003: Hyperthermia induced pathophysiology of the central nervous system. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 19(3): 325-354
Liebregts, M.T.; McLachlan, R.S.; Leung, L.S. 2002: Hyperthermia induces age-dependent changes in rat hippocampal excitability. Annals of Neurology 52(3): 318-326
Schiaffonati, L.; Maroni, P.; Bendinelli, P.; Tiberio, L.; Piccoletti, R. 2001: Hyperthermia induces gene expression of heat shock protein 70 and phosphorylation of mitogen activated protein kinases in the rat cerebellum. Neuroscience Letters 312(2): 75-78
Grisé, K.; Kim, F.; McFadden, D. 2000: Hyperthermia induces heat-shock protein expression, reduces pancreatic injury, and improves survival in necrotizing pancreatitis. Pancreas 21(2): 120-125
Tashiro, M.; Ernst, S.A.; Edwards, J.; Williams, J.A. 2002: Hyperthermia induces multiple pancreatic heat shock proteins and protects against subsequent arginine-induced acute pancreatitis in rats. Digestion 65(2): 118-126
Roca, C.; Primo, L.; Valdembri, D.; Cividalli, A.; Declerck, P.; Carmeliet, P.; Gabriele, P.; Bussolino, F. 2003: Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Research 63(7): 1500-1507
Redaelli, C.A.; Tien, Y-Hua.; Kubulus, D.; Mazzucchelli, L.; Schilling, M.K.; Wagner, A.C.C. 2002: Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 90(4): 489-497
Wilson, N.; Mcardle, A.; Guerin, D.; Tasker, H.; Wareing, P.; Foster, C.S.; Jackson, M.J.; Rhodes, L.E. 2000: Hyperthermia to normal human skin in vivo upregulates heat shock proteins 27, 60, 72i and 90. Journal of Cutaneous Pathology 27(4): 176-182
Lagendijk, J.J.W. 2000: Hyperthermia treatment planning. Physics in Medicine and Biology 45(5): R61-R76
Metzler, W.; Höfken, T.; Weber, H.; Printz, H.; Göke, B.; Wagner, A.C. 1999: Hyperthermia, inducing pancreatic heat-shock proteins, fails to prevent cerulein-induced stress kinase activation. Pancreas 19(2): 150-157
Stewart, C.W.; Slikker, W. 1999: Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats. Brain Research 839(2): 279-282
Stewart, C.W.; Slikker, W. 1999: Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-Fenfluramine exposure is preventable. Life Sciences 65(15): 1531-1536
Islam, M.S.; Mitsuhashi, N.; Akimoto, T.; Sakurai, H.; Hasegawa, M.; Ishikawa, H.; Niibe, H. 2001: Hyperthermia-induced apoptosis in two rat yolk sac tumor cell lines with different radiothermosensitivity in vitro. Oncology Reports 8(3): 501-507
Goto, A.; Shomori, K.; Ohkumo, T.; Tanaka, F.; Sato, K.; Ito, H. 1999: Hyperthermia-induced apoptosis occurs both in a p53 gene-dependent and -independent manner in three human gastric carcinoma cell lines. Oncology Reports 6(2): 335-339
Barni, S.; Pontiggia, P.; Bertone, V.; Vaccarone, R.; Silvotti, M.G.; Pontiggia, E.; Mathé, G. 2001: Hyperthermia-induced cell death by apoptosis in myeloma cells. Biomedicine and PharmacoTherapy 55(3): 170-173
Matthew; DuBose; Sils; Tartartini 2000: Hyperthermia-induced changes in the vascular permeability of rats: A model system to examine therapeutic interventions. Journal of Thermal Biology 25(5): 381-386
Stein, U.; Jürchott, K.; Walther, W.; Bergmann, S.; Schlag, P.M.; Royer, H.D. 2001: Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. Journal of Biological Chemistry 276(30): 28562-28569
Di Filippo, F.; Rossi, C.R.; Vaglini, M.; Azzarelli, A.; Anzà, M.; Santinami, M.; Lise, M.; Cavaliere, F.; Giannarelli, D.; Quagliuolo, V.; Vecchiato, A.; Deraco, M.; Garinei, R.; Foletto, M.; Botti, C.; Cavaliere, R. 1999: Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase i study. Journal of ImmunoTherapy 22(5): 407-414
Pataki, I.; Jászberényi, M.; Telegdy, G. 1999: Hyperthermic effect of centrally administered natriuretic peptides in the rat. Peptides 20(2): 193-197
DuBose; Matthew; Balcius; Morehouse; Sils 2000: Hyperthermic effects on reticuloendothelial system particulate uptake. Journal of Thermal Biology 25(5): 387-390
Othman, T.; Goto, S.; Lee, J.B.; Taimura, A.; Matsumoto, T.; Kosaka, M. 2001: Hyperthermic enhancement of the apoptotic and antiproliferative activities of paclitaxel. Pharmacology 62(4): 208-212
Krueger-Naug, A.M.; Hopkins, D.A.; Armstrong, J.N.; Plumier, J.C.; Currie, R.W. 2000: Hyperthermic induction of the 27-kDa heat shock protein (Hsp27) in neuroglia and neurons of the rat central nervous system. Journal of Comparative Neurology 428(3): 495-510
Vocelka, C.R.; Anderson, D.L.; Crockett, G.I. 2000: Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two-pump system: a case report. Perfusion 15(6): 549-552
Rossi, C.R.; Foletto, M.; Mocellin, S.; Pilati, P.; De, S.M.; Deraco, M.; Cavaliere, F.; Palatini, P.; Guasti, F.; Scalerta, R.; Lise, M. 2002: Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase i study. Cancer 94(2): 492-499
Olieman, A.F.; van Ginkel, R.J.; Molenaar, W.M.; Schraffordt Koops, H.; Hoekstra, H.J. 1998: Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?. Archives of Orthopaedic and Trauma Surgery 118(1-2): 70-74
Katschinski, D.M.; Robins, H.I. 1999: Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity. International Journal of Cancer 80(1): 104-109
Yellin, A.; Simansky, D.A.; Paley, M.; Refaely, Y. 2001: Hyperthermic pleural perfusion with cisplatin: Early clinical experience. Cancer 92(8): 2197-2203
Kwong, J.M.K.; Lam, T.T.; Caprioli, J. 2003: Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-induced apoptosis in rat. Brain Research 970(1-2): 119-130
Zeise, E.; Rensing, L. 2002: Hyperthermic pre-treatment protects rat IPC-81 leukaemia cells against heat- and hydrogen peroxide-induced apoptosis. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 18(4): 344-360
Ikeda, T.; Xia, X.Y.; Xia, Y.X.; Ikenoue, T. 1999: Hyperthermic preconditioning prevents blood-brain barrier disruption produced by hypoxia-ischemia in newborn rat. Brain Research. Developmental Brain Research 117(1): 53-58
Chen, S.C.; Lu, T.S.; Lee, H.L.; Lue, S.I.; Yang, R.C. 2001: Hyperthermic pretreatment decreases microvascular protein leakage and attenuates hypotension in anaphylactic shock in rats. Microvascular Research 61(2): 152-159
Schlag, P.M.; Benhidjeb, T.; Budach, V. 1999: Hyperthermic radiochemotherapy for esophageal cancer-Rationale and concept of a phase III trial. Onkologie 22(1): 48-52
Kampinga, H.H.; Dikomey, E. 2001: Hyperthermic radiosensitization: mode of action and clinical relevance. International Journal of Radiation Biology 77(4): 399-408
Wiley, D.; Sheaff, C.; Nagy, K.; Reiman, H.; Leslie, C.; Barrett, J. 2000: Hyperthermic resuscitation is safe and effective after hemorrhagic shock in dogs. Journal of Trauma 48(6): 1052-6; Discussion 1056-7
Wu, J.; Fisher, R.S. 2000: Hyperthermic spreading depressions in the immature rat hippocampal slice. Journal of Neurophysiology 84(3): 1355-1360
Zivadinovic, D.; Vidovic, S.; Matic, G.; Andjus, R.K. 2001: Hyperthermic stress affects the thermal modulation of glucocorticoid-receptor affinity. Journal of Thermal Biology 26(6): 575-584
Cvoro, A.; Matić, G. 2002: Hyperthermic stress stimulates the association of both constitutive and inducible isoforms of 70 kDa heat shock protein with rat liver glucocorticoid receptor. International Journal of Biochemistry and Cell Biology 34(3): 279-285
Miller, M.W.; Nyborg, W.L.; Dewey, W.C.; Edwards, M.J.; Abramowicz, J.S.; Brayman, A.A. 2002: Hyperthermic teratogenicity, thermal dose and diagnostic ultrasound during pregnancy: implications of new standards on tissue heating. International Journal of Hyperthermia: the Official Journal of European Society for Hyperthermic Oncology North American Hyperthermia Group 18(5): 361-384
Viard, T.; Lamour, V.; Duguet, M.; Bouthier de la Tour, C. 2001: Hyperthermophilic topoisomerase i from Thermotoga maritima. a very efficient enzyme that functions independently of zinc binding. Journal of Biological Chemistry 276(49): 46495-46503
Islas, S.; Velasco, A.M.; Becerra, A.; Delaye, L.; Lazcano, A. 2003: Hyperthermophily and the origin and earliest evolution of life. International Microbiology: the Official Journal of the Spanish Society for Microbiology 6(2): 87-94
Declerck, N.; Machius, M.; Joyet, P.; Wiegand, G.; Huber, R.; Gaillardin, C. 2003: Hyperthermostabilization of Bacillus licheniformis alpha-amylase and modulation of its stability over a 50 degrees C temperature range. Protein Engineering 16(4): 287-293
Ando, S.; Ishida, H.; Kosugi, Y.; Ishikawa, K. 2002: Hyperthermostable endoglucanase from Pyrococcus horikoshii. Applied and Environmental Microbiology 68(1): 430-433
Hashimoto, H.; Inoue, T.; Nishioka, M.; Fujiwara, S.; Takagi, M.; Imanaka, T.; Kai, Y. 1999: Hyperthermostable protein structure maintained by intra and inter-helix ion-pairs in archaeal O6-methylguanine-DNA methyltransferase. Journal of Molecular Biology 292(3): 707-716
Prochnik, S.; Fantes, P. 2001: Hyperthermotolerant fission yeast mutations, sow1 and sow2, suppress the cell cycle defect and stress sensitivity of MAP kinase kinase wis1Delta. Yeast 18(3): 229-238
Misaki, T.; Iwata, M.; Kasagi, K.; Iida, Y.; Akamizu, T.; Kosugi, S.; Konishi, J. 2000: Hyperthyroid Graves' disease after hemithyroidectomy for papillary carcinoma: report of three cases. Endocrine Journal 47(2): 191-195
Fukui, T.; Hasegawa, Y.; Takenaka, H. 2001: Hyperthyroid dementia: Clinicoradiological findings and response to treatment. Journal of the Neurological Sciences 184(1): 81-88
Brunova, J.; Bruna, J.; Mollentze, W.; Meyer, G.M. 1999: Hyperthyroidism caused by TSH-producing adenoma. SAMJ (South African Medical Journal) 89(11): 1210-1214
Yuan, P.Q.; Yang, H. 1999: Hyperthyroidism decreases thyrotropin-releasing hormone gene expression in the caudal raphe nuclei and the parapyramidal regions in rats. Neuroscience Letters 276(3): 189-192
Büssemaker, E.; Popp, R.; Fisslthaler, B.; Larson, C.M.; Fleming, I.; Busse, R.; Brandes, R.P. 2003: Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery. Cardiovascular Research 59(1): 181-188
Peces, R.; Navascués, R.A.; Baltar, J.; Laurés, A.S.; Ortega, F.; Alvarez-Grande, J. 1998: Hyperthyroidism in a renal transplant recipient. American Journal of Nephrology 18(6): 560-561
Findlay, P.F.; Seymour, D.G. 2000: Hyperthyroidism in an elderly patient. Postgraduate Medical Journal 76(893): 173-175
Díez, J.J. 2003: Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 49(5): 316-323
Narasimhan, K.L.; Ghobrial, M.W.; Ruby, E.B. 2002: Hyperthyroidism in the setting of gestational trophoblastic disease. American Journal of the Medical Sciences 323(5): 285-287
Kettaneh, A.; Prevot, S.; Biaggi, A.; Stirnemann, J.; Fain, O.; Hocqueloux, L.; Mouas, H.; Levy, V.G.; Thomas, M. 2003: Hyperthyroidism in two patients with Crohn disease and Takayasu arteritis. Scandinavian Journal of Gastroenterology 38(8): 901-903
Huffman, L.J.; Judy, D.J.; Brumbaugh, K.; Frazer, D.G.; Reynolds, J.S.; McKinney, W.G.; Goldsmith, W.T. 2001: Hyperthyroidism increases the risk of ozone-induced lung toxicity in rats. Toxicology and Applied Pharmacology 173(1): 18-26
Zaucha, J.M.; Sworczak, K.; Siekierska Hellmann, M.; Hellmann, A. 1998: Hyperthyroidism induced by interferon alpha therapy in patient with chronic myelogenous leukaemia. Acta Haematologica Polonica 29(2): 291-293
Colzani, R.M.; Emdin, M.; Conforti, F.; Passino, C.; Scarlattini, M.; Iervasi, G. 2001: Hyperthyroidism is associated with lengthening of ventricular repolarization. Clinical Endocrinology 55(1): 27-32
Pantos, C.I.; Cokkinos, D.D.; Tzeis, S.M.; Malliopoulou, V.; Mourouzis, I.S.; Carageorgiou, H.C.; Limas, C.; Varonos, D.V.; Cokkinos, D.V. 1999: Hyperthyroidism is associated with preserved preconditioning capacity but intensified and accelerated ischaemic contracture in rat heart. Basic Research in Cardiology 94(4): 254-260
Herwig, U.; Sturzenegger, M. 1999: Hyperthyroidism mimicking increased intracranial pressure. Headache 39(3): 228-230
Dimai, H.P.; Ramschak-Schwarzer, S.; Lax, S.; Lipp, R.W.; Leb, G. 1999: Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient. Journal of Endocrinological Investigation 22(3): 215-219
Noto, H.; Mitsuhashi, T.; Ishibashi, S.; Kimura, S. 2000: Hyperthyroidism presenting as dysphagia. Internal Medicine 39(6): 472-473
Maes, J.; Michotte, A.; Velkeniers, B.; Stadnik, T.; Jochmans, K. 2002: Hyperthyroidism with increased factor VIIi procoagulant protein as a predisposing factor for cerebral venous thrombosis. Journal of Neurology Neurosurgery and Psychiatry 73(4): 458
Viallard, J.F.; Tabarin, A.; Neau, D.; Longy-Boursier, M. 1999: Hyperthyroidism with severe intrahepatic cholestasis. Digestive Diseases and Sciences 44(10): 2001-2002
Paul, E.; Van Why, S.; Carpenter, T.O. 1999: Hyperthyroidism: a novel feature of the tubulointerstitial nephritis and uveitis syndrome. Pediatrics 104(2 Pt 1): 314-317
Wehner, F.; Shimizu, T.; Sabirov, R.; Okada, Y. 2003: Hypertonic activation of a non-selective cation conductance in HeLa cells and its contribution to cell volume regulation. FEBS Letters 551(1-3): 20-24
Kirschner, U.; Van Driessche, W.; Werner, A.; Wehner, F. 2003: Hypertonic activation of phospholemman in solitary rat hepatocytes in primary culture. FEBS Letters 537(1-3): 151-156
Basham, J.C.; Chabrerie, A.; Kempson, S.A. 2001: Hypertonic activation of the renal betaine/GABA transporter is microtubule dependent. Kidney International 59(6): 2182-2191
Kashani, A.H.; Chen, B.M.; Grinnell, A.D.; Grinnell, A.D. 2001: Hypertonic enhancement of transmitter release from frog motor nerve terminals: Ca2+ independence and role of integrins. Journal of Physiology 530(Pt 2): 243-252
Butler, D.G. 2002: Hypertonic fluids are secreted by medial and lateral segments in duck (Anas platyrhynchos) nasal salt glands. Journal of Physiology 540(Pt 3): 1039-1046
Weller, A.; Tsitolovskya, L.; Smith, G.P. 2001: Hypertonic glucose preloads act preabsorptively to decrease intake in rats on postnatal day 18. Physiology and Behavior 72(1-2): 199-203
Rizoli, S.B.; Kapus, A.; Parodo, J.; Fan, J.; Rotstein, O.D. 1999: Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression. Journal of Surgical Research 83(2): 130-135
Hoffert, J.D.; Leitch, V.; Agre, P.; King, L.S. 2000: Hypertonic induction of aquaporin-5 expression through an ERK-dependent pathway. Journal of Biological Chemistry 275(12): 9070-9077
Rizoli, S.B.; Rotstein, O.D.; Parodo, J.; Phillips, M.J.; Kapus, A. 2000: Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. American Journal of Physiology. Cell Physiology 279(3): C619-C633
Hess, D.C.; Howard, E.; Cheng, C.; Carroll, J.; Hill, W.D.; Hsu, C.Y. 2000: Hypertonic mannitol loading of NF-kappaB transcription factor decoys in human brain microvascular endothelial cells blocks upregulation of ICAM-1. Stroke 31(5): 1179-1186
Cuschieri, J.; Gourlay, D.; Garcia, I.; Jelacic, S.; Maier, R.V. 2002: Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. Journal of Immunology 168(3): 1389-1396
Wilder, D.M.; Reid, T.J.; Bakaltcheva, I.B. 2002: Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thrombosis Research 107(5): 255-261
Powers, K.A.; Woo, J.; Khadaroo, R.G.; Papia, G.; Kapus, A.; Rotstein, O.D. 2003: Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery 134(2): 312-318
Alves, S.Hartz.; Milan, E.Pipolo.; de Laet Sant'Ana, P.; Oliveira, L.O.; Santurio, J.M.; Colombo, A.Lopes. 2002: Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagnostic Microbiology and Infectious Disease 43(1): 85-86
Järvelä, K.; Kaukinen, S. 2001: Hypertonic saline (7.5%) after coronary artery bypass grafting. European Journal of Anaesthesiology 18(2): 100-107
Suzuki, R.; Freed, A.N. 2000: Hypertonic saline aerosol increases airway reactivity in the canine lung periphery. Journal of Applied Physiology 89(6): 2139-2146
Ciesla, D.J.; Moore, E.E.; Musters, R.J.; Biffl, W.L.; Silliman, C.A. 2001: Hypertonic saline alteration of the PMN cytoskeleton: implications for signal transduction and the cytotoxic response. Journal of Trauma 50(2): 206-212
Middleton, P.G.; Pollard, K.A.; Wheatley, J.R. 2001: Hypertonic saline alters ion transport across the human airway epithelium. European Respiratory Journal 17(2): 195-199
Pascual, J.é L.; Khwaja, K.A.; Chaudhury, P.; Christou, N.V. 2003: Hypertonic saline and the microcirculation. Journal of Trauma 54(5 Suppl): S133-S140
Ciesla, D.J.; Moore, E.E.; Zallen, G.; Biffl, W.L.; Silliman, C.C. 2000: Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. Journal of Trauma 48(3): 388-395
Ciesla, D.J.; Moore, E.E.; Biffl, W.L.; Gonzalez, R.J.; Silliman, C.C. 2001: Hypertonic saline attenuation of the neutrophil cytotoxic response is reversed upon restoration of normotonicity and reestablished by repeated hypertonic challenge. Surgery 129(5): 567-575
Corso, C.O.; Okamoto, S.; Rüttinger, D.; Messmer, K. 1999: Hypertonic saline dextran attenuates leukocyte accumulation in the liver after hemorrhagic shock and resuscitation. Journal of Trauma 46(3): 417-423
Gurfinkel, V.; Poggetti, R.S.ér.; Fontes, B.; da Costa Ferreira Novo, F.; Birolini, D. 2003: Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. Journal of Trauma 54(6): 1137-1145
Greiff, L.; Andersson, M.; Wollmer, P.; Persson, C.G.A. 2003: Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo. European Respiratory Journal 21(2): 308-312
Högman, M.; Mörk, A.C.; Roomans, G.M. 2002: Hypertonic saline increases tight junction permeability in airway epithelium. European Respiratory Journal 20(6): 1444-1448